J. C. Wagner, C. A. Sleggs, and P. Marchand, Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province, Br J Ind Med, vol.17, pp.260-71, 1960.

G. Zalcman, J. Mazieres, J. Margery, L. Greillier, C. Audigier-valette et al., Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, The Lancet, vol.387, pp.1405-1414, 2016.

R. Bueno, E. W. Stawiski, L. D. Goldstein, S. Durinck, D. Rienzo et al.,

, Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations, Nat Genet, vol.48, pp.407-423, 2016.

Z. Meng, T. Moroishi, and K. Guan, Mechanisms of Hippo pathway regulation, Genes Dev, vol.30, pp.1-17, 2016.

F. Qin, J. Tian, D. Zhou, and L. Chen, Mst1 and Mst2 kinases: regulations and diseases, Cell Biosci, vol.3, p.31, 2013.
DOI : 10.1186/2045-3701-3-31

URL : https://cellandbioscience.biomedcentral.com/track/pdf/10.1186/2045-3701-3-31

A. Bitra, S. Sistla, J. Mariam, H. Malvi, and R. Anand, Rassf Proteins as Modulators of Mst1 Kinase Activity, Sci Rep, vol.7, p.45020, 2017.

C. Guo, X. Zhang, and G. P. Pfeifer, The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2, J Biol Chem, vol.286, pp.6253-61, 2011.

C. Servas, S. Kiehlmeier, J. Hach, R. Gross, C. Götz et al., The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2, Cell Signal, vol.36, pp.163-75, 2017.

S. Chiba, M. Ikeda, K. Katsunuma, K. Ohashi, and K. Mizuno, MST2-and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes, Curr Biol CB, vol.19, pp.675-81, 2009.

C. Guo, S. Tommasi, L. Liu, J. Yee, R. Dammann et al., RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network, Curr Biol CB, vol.17, pp.700-705, 2007.

A. Hergovich, R. S. Kohler, D. Schmitz, A. Vichalkovski, H. Cornils et al., The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation, Curr Biol CB, vol.19, pp.1692-702, 2009.

M. Praskova, F. Xia, and J. Avruch, MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation, Curr Biol CB, vol.18, pp.311-332, 2008.
DOI : 10.1016/j.cub.2008.02.006

URL : https://doi.org/10.1016/j.cub.2008.02.006

A. Robertson, T. Mohamed, E. Maadawi, Z. Stafford, N. Bui et al., Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival, Stem Cell Res, vol.20, pp.42-51, 2017.

K. Katagiri, T. Katakai, Y. Ebisuno, Y. Ueda, T. Okada et al., Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes, EMBO J, vol.28, pp.1319-1350, 2009.
DOI : 10.1038/emboj.2009.82

URL : http://emboj.embopress.org/content/28/9/1319.full.pdf

Y. Liang, K. Li, K. Riecken, A. Maslyukov, D. Gomez-nicola et al., Long-term in vivo single-cell tracking reveals the switch of migration patterns in adult-born juxtaglomerular cells of the mouse olfactory bulb, Cell Res, vol.26, pp.805-826, 2016.

X. Xu, X. Wang, E. M. Todd, E. R. Jaeger, J. L. Vella et al., Mst1 Kinase Regulates the Actin-Bundling Protein L-Plastin To Promote T Cell Migration, J Immunol, vol.197, pp.1683-91, 2016.
DOI : 10.4049/jimmunol.1600874

URL : http://www.jimmunol.org/content/197/5/1683.full.pdf

F. De-fraipont, G. Levallet, C. Creveuil, E. Bergot, M. Beau-faller et al., An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial, Clin Cancer Res Off J Am Assoc Cancer Res, vol.18, pp.2976-86, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00718845

C. Seidel, U. Schagdarsurengin, K. Blümke, P. Würl, G. P. Pfeifer et al., Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma, Mol Carcinog, vol.46, pp.865-71, 2007.

G. Levallet, M. Vaisse-lesteven, N. L. Stang, A. Ilg, P. Brochard et al., Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group, J Thorac Oncol, vol.7, pp.599-606, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01853402

F. Dubois, M. Keller, O. Calvayrac, F. Soncin, L. Hoa et al., RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway, Cancer Res, vol.76, pp.1627-1667, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02037182

N. Yang, C. D. Morrison, P. Liu, J. Miecznikowski, W. Bshara et al., TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin, Cell Cycle, vol.11, pp.2922-2952, 2012.

G. A. Woodard, Y. Yang, L. You, and D. M. Jablons, Drug development against the hippo pathway in mesothelioma, Transl Lung Cancer Res, vol.6, pp.335-377, 2017.

K. Steinmann, A. Sandner, U. Schagdarsurengin, and R. H. Dammann, Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma, Oncol Rep, vol.22, pp.1519-1545, 2009.

T. Fukuhara, T. Tomiyama, K. Yasuda, Y. Ueda, Y. Ozaki et al., Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis, Biochem Biophys Res Commun, vol.463, pp.968-74, 2015.

A. Miyanaga, M. Masuda, K. Tsuta, K. Kawasaki, Y. Nakamura et al., Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing, J Thorac Oncol, vol.10, pp.844-51, 2015.

Y. Sekido, Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation: Merlin inactivation in mesothelioma, Pathol Int, vol.61, pp.331-375, 2011.

R. Tranchant, L. Quetel, A. Tallet, C. Meiller, A. Renier et al., Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma, Clin Cancer Res, vol.23, pp.3191-202, 2017.

X. Lin, F. Cai, X. Li, X. Kong, C. Xu et al., Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer, Tumor Biol, vol.34, pp.3239-3282, 2013.

B. H. Sohn, J. Shim, S. Kim, K. Y. Jang, S. M. Kim et al., Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma, Clin Cancer Res, vol.22, pp.1256-64, 2016.

J. Yu, X. Zhai, X. Li, C. Zhong, C. Guo et al., Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach, vol.7, 2017.

S. Attarha, S. Andersson, M. Mints, and S. Souchelnytskyi, Mammalian sterile-like 1 kinase inhibits TGF? and EGF-dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells, Int J Oncol, vol.45, pp.853-60, 2014.

E. Fallahi, N. O'driscoll, and D. Matallanas, The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair, Genes, vol.7, p.28, 2016.

J. A. Galan and J. Avruch, MST1/MST2 Protein Kinases: Regulation and Physiologic Roles, Biochemistry (Mosc), vol.55, pp.5507-5526, 2016.

H. J. Oh, K. Lee, S. J. Song, M. S. Jin, M. S. Song et al., Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis, Cancer Res, vol.66, pp.2562-2571, 2006.

C. Xu, C. Liu, W. Huang, S. Tu, and F. Wan, Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro, Acta Biochim Biophys Sin, vol.45, pp.268-79, 2013.

C. M. Xu, W. W. Liu, C. J. Liu, C. Wen, H. F. Lu et al., Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo, Cancer Gene Ther, vol.20, pp.453-60, 2013.

X. Zhou, Y. Li, Y. Zhang, Y. Xu, D. Yuan et al., Expression of YAP and Inhibitory Effect By IGF-1R Suppressor in Diffuse Large B-Cell Lymphoma, Blood, vol.128, pp.892-892, 2016.

F. Neto, A. Klaus-bergmann, Y. T. Ong, S. Alt, A. Vion et al., YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development. eLife, vol.7, 2018.

C. G. Hansen, T. Moroishi, K. Guan, . Yap, and . Taz, Trends Cell Biol, vol.25, pp.499-513, 2015.

A. J. Knights, A. Funnell, M. Crossley, and R. Pearson, Holding Tight: Cell Junctions and Cancer Spread, Trends Cancer Res, vol.8, pp.61-70, 2012.

W. Zhang, Y. Dai, P. Hsu, H. Wang, L. Cheng et al., Targeting YAP in malignant pleural mesothelioma, J Cell Mol Med, 2017.

,

C. Wang, X. Zhu, W. Feng, Y. Yu, K. Jeong et al., Verteporfin inhibits YAP function through up-regulating 14-3-3? sequestering YAP in the cytoplasm, Am J Cancer Res, vol.6, p.27, 2016.

L. Hesson, I. Bièche, D. Krex, E. Criniere, K. Hoang-xuan et al., Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas, Oncogene, vol.23, pp.2408-2427, 2004.

L. B. Hesson, R. Wilson, D. Morton, C. Adams, M. Walker et al., CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations, Oncogene, vol.24, pp.3987-94, 2005.

U. Schagdarsurengin, O. Gimm, C. Hoang-vu, H. Dralle, G. P. Pfeifer et al., Frequent Epigenetic Silencing of the CpG Island Promoter of RASSF1A in Thyroid Carcinoma, Cancer Res, vol.62, pp.3698-701, 2002.

H. Abdollahpour, G. Appaswamy, D. Kotlarz, J. Diestelhorst, R. Beier et al., The phenotype of human STK4 deficiency, Blood, vol.119, pp.3450-3457, 2012.

R. M. Adam, S. G. Chamberlin, and D. E. Davies, Induction of anchorage-independent growth by amphiregulin, Growth Factors Chur Switz, vol.13, pp.193-203, 1996.

A. Agathanggelou, W. N. Cooper, and F. Latif, Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers, Cancer Res, vol.65, pp.3497-3508, 2005.

A. Al-kaabi, L. W. Van-bockel, A. J. Pothen, and S. M. Willems, p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review, Dis. Markers, p.260549, 2014.

M. Andersen, M. Grauslund, J. Ravn, J. B. Sørensen, C. B. Andersen et al., , 2014.

, Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma, J. Mol. Diagn, vol.16, pp.418-430

P. Andujar, A. Lacourt, P. Brochard, J. Pairon, M. Jaurand et al., Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles, J. Toxicol. Environ. Health B Crit. Rev, vol.19, pp.151-172, 2016.

K. Aoe, A. Hiraki, T. Tanaka, K. Gemba, K. Taguchi et al., Expression of Vascular Endothelial Growth Factor in Malignant Mesothelioma, Anticancer Res, vol.26, pp.4833-4836, 2006.

M. Aragona, T. Panciera, A. Manfrin, S. Giulitti, F. Michielin et al.,

, A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by ActinProcessing Factors, Cell, vol.154, pp.1047-1059

C. Arnette, N. Efimova, X. Zhu, G. J. Clark, and I. Kaverina, Microtubule segment stabilization by RASSF1A is required for proper microtubule dynamics and Golgi integrity, Mol. Biol. Cell, vol.25, pp.800-810, 2014.

V. Ascoli, D. Cavone, E. Merler, P. G. Barbieri, L. Romeo et al., Mesothelioma in blood related subjects: Report of 11 clusters among 1954 Italy cases and review of the literature, Am. J. Ind. Med, vol.50, pp.357-369, 2007.

T. Asplund and P. Heldin, Hyaluronan Receptors Are Expressed on Human Malignant Mesothelioma Cells but not on Normal Mesothelial Cells, Cancer Res, vol.54, pp.4516-4523, 1994.

L. V. De-assis, J. Locatelli, and M. C. Isoldi, The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma, Biochim. Biophys. Acta BBA -Rev. Cancer, vol.1845, pp.232-247, 2014.

J. Avruch, M. Praskova, S. Ortiz-vega, M. Liu, and X. Zhang, Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases, Methods Enzymol, vol.407, pp.290-310, 2006.

J. Avruch, D. Zhou, J. Fitamant, N. Bardeesy, F. Mou et al., Protein Kinases of the Hippo Pathway: Regulation and Substrates, Semin. Cell Dev. Biol, vol.23, pp.770-784, 2012.

L. Azzolin, T. Panciera, S. Soligo, E. Enzo, S. Bicciato et al., YAP/TAZ Incorporation in the ?-Catenin Destruction Complex Orchestrates the Wnt Response, Cell, vol.158, pp.157-170, 2014.

N. Bai, C. Zhang, N. Liang, Z. Zhang, A. Chang et al., Yesassociated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53, Cancer Biol. Ther, vol.14, pp.511-520, 2013.

Y. Bai, Y. -. Liu, H. Wang, Y. Xu, I. Stamenkovic et al., Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin, Oncogene, vol.26, p.836, 2007.

A. Baillo, C. Giroux, and S. P. Ethier, Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer., Knock-down of Amphiregulin Inhibits Cellular Invasion in Inflammatory Breast Cancer, J. Cell. Physiol. J. Cell. Physiol, vol.226, pp.2691-2701, 2011.

Y. I. Baris and P. Grandjean, Prospective Study of Mesothelioma Mortality in Turkish Villages With Exposure to Fibrous Zeolite, JNCI J. Natl. Cancer Inst, vol.98, pp.414-417, 2006.

I. Baris, L. Simonato, M. Artvinli, F. Pooley, R. Saracci et al., , 1987.

, Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey, Int. J. Cancer, vol.39, pp.10-17

D. Basu, R. Lettan, K. Damodaran, S. Strellec, M. Reyes-mugica et al., Identification, Mechanism of Action, and Antitumor Activity of a Small Molecule Inhibitor of Hippo, TGF-?, and Wnt Signaling Pathways, Mol. Cancer Ther, vol.13, pp.1457-1467, 2014.

S. Basu, N. F. Totty, M. S. Irwin, M. Sudol, and J. Downward, Akt Phosphorylates the Yes-Associated Protein, YAP, to Induce Interaction with 14-3-3 and Attenuation of p73-Mediated Apoptosis, Mol. Cell, vol.11, pp.11-23, 2003.

S. Batra, Y. Shi, K. M. Kuchenbecker, B. He, N. Reguart et al., Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma, Biochem. Biophys. Res. Commun, vol.342, pp.1228-1232, 2006.

S. Benedetti, B. Nuvoli, S. Catalani, and R. Galati, Reactive oxygen species a double-edged sword for mesothelioma, Oncotarget, vol.6, p.16848, 2015.

K. L. Bennett, D. G. Jackson, J. C. Simon, E. Tanczos, R. Peach et al., CD44 isoforms containing exon V3 are responsible for the presentation of heparinbinding growth factor, J. Cell Biol, vol.128, pp.687-698, 1995.

C. Berasain and M. A. Avila, Amphiregulin. Semin. Cell Dev. Biol, vol.28, pp.31-41, 2014.

E. Bertini, T. Oka, M. Sudol, S. Strano, and G. Blandino, YAP: At the crossroad between transformation and tumor suppression, Cell Cycle, vol.8, pp.49-57, 2009.

M. Betti, E. Casalone, D. Ferrante, A. Romanelli, F. Grosso et al., Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area, Genes. Chromosomes Cancer, vol.54, pp.51-62, 2015.

K. P. Bhat, K. L. Salazar, V. Balasubramaniyan, K. Wani, L. Heathcock et al., The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma, Genes Dev, vol.25, pp.2594-2609, 2011.

A. B. Bianchi, S. Mitsunaga, J. Q. Cheng, W. M. Klein, S. C. Jhanwar et al., High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas, Proc. Natl. Acad. Sci, vol.92, pp.10854-10858, 1995.

A. Bitra, S. Sistla, J. Mariam, H. Malvi, A. et al., Rassf Proteins as Modulators of Mst1 Kinase Activity. Sci. Rep. 7, p.45020, 2017.

M. A. Blasco, Telomerase beyond telomeres, Nat. Rev. Cancer, vol.2, pp.627-633, 2002.

J. C. Boggiano, P. J. Vanderzalm, and R. G. Fehon, Tao-1 Phosphorylates Hippo/MST kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway, Dev. Cell, vol.21, pp.888-895, 2011.

M. C. Bois, A. S. Mansfield, W. R. Sukov, S. M. Jenkins, J. C. Moser et al., c-Met expression and MET amplification in malignant pleural mesothelioma, Ann. Diagn. Pathol, vol.23, pp.1-7, 2016.

M. A. Bonelli, C. Fumarola, S. La-monica, A. , and R. , New therapeutic strategies for malignant pleural mesothelioma, Biochem. Pharmacol, vol.123, pp.8-18, 2017.

M. A. Bonelli, G. Digiacomo, C. Fumarola, R. Alfieri, F. Quaini et al., Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells, vol.19, pp.637-648, 2017.

M. Bott, M. Brevet, B. S. Taylor, S. Shimizu, T. Ito et al., The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma, Nat. Genet, vol.43, pp.668-672, 2011.

L. Y. Bourguignon, Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression, Small GTPases, vol.3, pp.53-59, 2012.

L. Y. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad, Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells, J. Biol. Chem, vol.283, pp.17635-17651, 2008.

L. Y. Bourguignon, M. Shiina, and J. Li, Chapter Ten -Hyaluronan-CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression, Advances in Cancer, pp.255-275, 2014.

N. Branzk, A. Lubojemska, S. E. Hardison, Q. Wang, M. G. Gutierrez et al., Neutrophils sense microbial size and selectively release neutrophil extracellular traps in response to large pathogens, Nat. Immunol, vol.15, pp.1017-1025, 2014.

M. Brevet, S. Shimizu, M. J. Bott, N. Shukla, Q. Zhou et al., , 2011.

, Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.6, pp.864-874

S. Brosseau, S. Assoun, C. Naltet, C. Steinmetz, V. Gounant et al., A review of bevacizumab in the treatment of malignant pleural mesothelioma, Future Oncol, 2017.

R. Bueno, E. W. Stawiski, L. D. Goldstein, S. Durinck, A. De-rienzo et al., Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations, Nat. Genet, vol.48, pp.407-416, 2016.

D. A. Bui, W. Lee, A. E. White, J. W. Harper, R. C. Schackmann et al., Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP, Sci. Signal, vol.9, p.23, 2016.

W. B. Bunn, J. R. Bender, T. W. Hesterberg, G. R. Chase, and J. L. Konzen, Recent studies of man-made vitreous fibers. Chronic animal inhalation studies, J. Occup. Med. Off. Publ. Ind. Med. Assoc, vol.35, pp.101-113, 1993.

B. Busser, L. Sancey, V. Josserand, C. Niang, M. C. Favrot et al., Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers, Mol. Ther, vol.18, pp.528-535, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00425468

B. Busser, L. Sancey, E. Brambilla, J. Coll, and A. Hurbin, The multiple roles of amphiregulin in human cancer, Biochim. Biophys. Acta BBA -Rev. Cancer, vol.1816, pp.119-131, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00602082

P. T. Cagle, A. , and T. C. , Pathology of the pleura: What the pulmonologists need to know: Pathology of the pleura, Respirology, vol.16, pp.430-438, 2011.

W. Cai, L. Wang, G. Liu, P. Zhu, C. Paul et al., Manipulating the Hippo-Yap signal cascade in stem cells for heart regeneration, Ann. Palliat. Med, vol.5, pp.125-134, 2016.

K. Campbell, S. Brosseau, L. Reviron-rabec, E. Bergot, E. Lechapt et al., Mésothéliomes malins pleuraux: le point en, Bull. Cancer (Paris), vol.100, pp.1283-1293, 2013.

M. Carbone, Y. , and H. , Mesothelioma: recent highlights, Ann. Transl. Med, vol.5, pp.238-238, 2017.

M. Carbone, S. Emri, A. U. Dogan, I. Steele, M. Tuncer et al., A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes, Nat. Rev. Cancer, vol.7, pp.147-154, 2007.

M. Carbone, Y. I. Baris, P. Bertino, B. Brass, S. Comertpay et al., Erionite exposure in North Dakota and Turkish villages with mesothelioma, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.13618-13623, 2011.

M. Carbone, B. H. Ly, R. F. Dodson, I. Pagano, P. T. Morris et al., Malignant mesothelioma: Facts, Myths, and Hypotheses, J. Cell. Physiol, vol.227, pp.44-58, 2012.
DOI : 10.1002/jcp.22724

URL : http://europepmc.org/articles/pmc3143206?pdf=render

L. Cassimeris, Accessory protein regulation of microtubule dynamics throughout the cell cycle, Curr. Opin. Cell Biol, vol.11, pp.134-141, 1999.

A. Cesario, A. Catassi, L. Festi, A. Imperatori, A. Pericelli et al., Farnesyltransferase Inhibitors and Human Malignant Pleural Mesothelioma: A First-Step Comparative Translational Study, Clin. Cancer Res, vol.11, pp.2026-2037, 2005.

E. H. Chan, M. Nousiainen, R. B. Chalamalasetty, A. Schäfer, E. A. Nigg et al., The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1, Oncogene, vol.24, pp.2076-2086, 2005.

S. W. Chan, C. J. Lim, Y. F. Chong, A. V. Pobbati, C. Huang et al., Hippo Pathwayindependent Restriction of TAZ and YAP by Angiomotin, J. Biol. Chem, vol.286, pp.7018-7026, 2011.

C. Chang, P. Yin, D. Yang, C. Wang, W. Hung et al.,

, Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells, Cell. Mol. Life Sci, vol.66, pp.1755-1765

M. H. Chang, H. K. Ahn, J. Lee, C. Jung, Y. Choi et al., Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors, Cancer, vol.117, pp.143-151, 2011.

C. Chayangsu and V. Sriuranpong, Serum amphiregulin in colorectal carcinoma and the correlation with liver metastasis, J. Clin. Oncol, vol.34, pp.15078-15078, 2016.

Y. Chen, Z. Fu, S. Xu, Y. Xu, and P. Xu, The prognostic value of CD44 expression in gastric cancer: A meta-Analysis, Biomed. Pharmacother, vol.68, pp.693-697, 2014.

T. Chernova, F. A. Murphy, S. Galavotti, X. Sun, I. R. Powley et al., Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf), Curr. Biol, vol.27, pp.3302-3314, 2017.

S. Chiba, M. Ikeda, K. Katsunuma, K. Ohashi, and K. Mizuno, MST2-and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes, Curr. Biol. CB, vol.19, pp.675-681, 2009.

S. Chiba, Y. Amagai, Y. Homma, M. Fukuda, and K. Mizuno, NDR2-mediated Rabin8 phosphorylation is crucial for ciliogenesis by switching binding specificity from phosphatidylserine to Sec15, EMBO J, vol.32, pp.874-885, 2013.
DOI : 10.1038/emboj.2013.32

URL : http://emboj.embopress.org/content/embojnl/32/6/874.full.pdf

L. R. Chirieac, J. A. Barletta, B. Y. Yeap, W. G. Richards, T. Tilleman et al., Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, pp.4544-4549, 2013.

E. Chung, P. W. Cook, C. A. Parkos, Y. Park, M. R. Pittelkow et al., Amphiregulin causes functional downregulation of adherens junctions in psoriasis, J. Invest. Dermatol, vol.124, pp.1134-1140, 2005.

B. Cinar, P. Fang, M. Lutchman, D. Di-vizio, R. M. Adam et al., The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1, EMBO J, vol.26, pp.4523-4534, 2007.

M. Cioce, F. Ganci, V. Canu, A. Sacconi, F. Mori et al., Protumorigenic effects of mir-145 loss in Malignant Pleural Mesothelioma, Oncogene, vol.33, pp.5319-5331, 2014.

A. L. Cleaver, K. Bhamidipaty, B. Wylie, T. Connor, C. Robinson et al., Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance, Carcinogenesis, vol.35, pp.407-414, 2014.

H. Cornils, R. S. Kohler, A. Hergovich, and B. A. Hemmings, Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression, Cell Cycle Georget. Tex, vol.10, pp.1897-1904, 2011.

L. Cortes-dericks and R. A. Schmid, CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives, Respir. Res, vol.18, 2017.

A. L. Couzens, S. Xiong, J. D. Knight, D. Y. Mao, S. Guettler et al., MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway, Mol. Cell. Proteomics MCP, vol.16, pp.1098-1110, 2017.

A. D. Cox and C. J. Der, The dark side of Ras: regulation of apoptosis, Oncogene, vol.22, pp.8999-9006, 2003.

C. L. Creasy and J. Chernoff, Cloning and characterization of a member of the MST subfamily of Ste20-like kinases, Gene, vol.167, pp.303-306, 1995.

C. L. Creasy, D. M. Ambrose, and J. Chernoff, The Ste20-like Protein Kinase, Mst1, Dimerizes and Contains an Inhibitory Domain, J. Biol. Chem, vol.271, pp.21049-21053, 1996.

R. Cutrone, J. Lednicky, G. Dunn, P. Rizzo, M. Bocchetta et al.,

, Some Oral Poliovirus Vaccines Were Contaminated with Infectious SV40 after 1961, Cancer Res, vol.65, pp.10273-10279

A. Dallol, A. Agathanggelou, S. Tommasi, G. P. Pfeifer, E. R. Maher et al., Involvement of the RASSF1A Tumor Suppressor Gene in Controlling Cell Migration, Cancer Res, vol.65, pp.7653-7659, 2005.

A. Dallol, W. N. Cooper, F. Al-mulla, A. Agathanggelou, E. R. Maher et al., Depletion of the Ras Association Domain Family 1, Isoform A-Associated Novel Microtubule-Associated Protein, C19ORF5/MAP1S, Causes Mitotic Abnormalities, Cancer Res, vol.67, pp.492-500, 2007.

R. Dammann, C. Li, J. Yoon, P. L. Chin, S. Bates et al., Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3, Nat. Genet, vol.25, pp.315-319, 2000.

T. Dan, S. M. Hewitt, N. Ohri, D. Ly, B. P. Soule et al., CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up, Breast Cancer Res. Treat, vol.143, pp.11-18, 2014.

A. Das, R. S. Fischer, D. Pan, and C. M. Waterman, YAP Nuclear Localization in the Absence of CellCell Contact Is Mediated by a Filamentous Actin-dependent, Myosin II-and Phospho-YAP-independent Pathway during Extracellular Matrix Mechanosensing, J. Biol. Chem, vol.291, pp.6096-6110, 2016.

A. De-reyniès, M. Jaurand, A. Renier, G. Couchy, I. Hysi et al., Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition, Clin. Cancer Res, vol.20, pp.1323-1334, 2014.

A. D. De-rienzo, M. A. Archer, B. Y. Yeap, N. Dao, D. Sciaranghella et al., Gender-Specific Molecular and Clinical Features underlie Malignant Pleural Mesothelioma, Cancer Res, vol.76, pp.319-328, 2016.

M. D. Deel, J. J. Li, L. E. Crose, and C. M. Linardic, A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas, Front. Oncol, vol.5, 2015.

D. P. Del-re, T. Matsuda, P. Zhai, Y. Maejima, M. R. Jain et al., Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL, Mol. Cell, vol.54, pp.639-650, 2014.

L. G. Dent, C. L. Poon, X. Zhang, J. L. Degoutin, M. Tipping et al., The GTPase regulatory proteins Pix and Git control tissue growth via the Hippo pathway, Curr. Biol. CB, vol.25, pp.124-130, 2015.

M. Deran, J. Yang, C. Shen, E. C. Peters, J. Fitamant et al., Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein, Cell Rep, vol.9, pp.495-503, 2014.

A. Destro, G. L. Ceresoli, M. Falleni, P. A. Zucali, E. Morenghi et al., EGFR overexpression in malignant pleural mesothelioma, Lung Cancer, vol.51, pp.207-215, 2006.

A. Destro, G. L. Ceresoli, E. Baryshnikova, I. Garassino, P. A. Zucali et al., Gene methylation in pleural mesothelioma: correlations with clinicopathological features and patient's follow-up, Lung Cancer Amst. Neth, vol.59, pp.369-376, 2008.

D. Agostino, S. Sorrentino, G. Ingallina, E. Valenti, F. Ferraiuolo et al., YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins, EMBO Rep, vol.17, pp.188-201, 2016.

I. Dianzani, L. Gibello, A. Biava, M. Giordano, M. Bertolotti et al., Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study, Mutat. Res, vol.599, pp.124-134, 2006.

H. Donninger, M. D. Vos, and G. J. Clark, The RASSF1A tumor suppressor, J. Cell Sci, vol.120, pp.3163-3172, 2007.

F. Dubois, M. Keller, O. Calvayrac, F. Soncin, L. Hoa et al., RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway, Cancer Res, vol.76, pp.1627-1640, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02037182

M. J. Duffy, E. Mckiernan, N. O'donovan, and P. M. Mcgowan, Role of ADAMs in Cancer Formation and Progression, Clin. Cancer Res, vol.15, pp.1140-1144, 2009.

S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti et al., Role of YAP/TAZ in mechanotransduction, Nature, vol.474, pp.179-183, 2011.

S. Dutta, S. Mana-capelli, M. Paramasivam, I. Dasgupta, H. Cirka et al., TRIP6 inhibits Hippo signaling in response to tension at adherens junctions, EMBO Rep, vol.19, pp.337-350, 2018.

N. Eckstein, K. Servan, L. Girard, D. Cai, G. Von-jonquieres et al., Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells, J. Biol. Chem, vol.283, pp.739-750, 2008.

J. Edwards, K. Abrams, J. Leverment, T. Spyt, D. Waller et al., Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems, Thorax, vol.55, pp.731-735, 2000.

A. Elosegui-artola, I. Andreu, A. E. Beedle, A. Lezamiz, M. Uroz et al., Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores, Cell, vol.171, pp.1397-1410, 2017.

K. Emoto, J. Z. Parrish, L. Y. Jan, J. , and Y. , The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance, Nature, vol.443, pp.210-213, 2006.

L. Enewold, E. Sharon, T. , and A. , Patterns of care and survival among patients with malignant mesothelioma in the United States, Lung Cancer, vol.112, pp.102-108, 2017.

E. A. Engels, H. A. Katki, N. M. Nielsen, J. F. Winther, H. Hjalgrim et al., Cancer Incidence in Denmark Following Exposure to Poliovirus Vaccine Contaminated With Simian Virus 40, JNCI J. Natl. Cancer Inst, vol.95, pp.532-539, 2003.

T. C. Erren, M. Jacobsen, and C. Piekarski, Synergy between asbestos and smoking on lung cancer risks, Epidemiol. Camb. Mass, vol.10, pp.405-411, 1999.

F. Esteban, J. J. Bravo, M. A. González-moles, M. Bravo, I. Ruiz-avila et al., , 2005.

, Adhesion molecule CD44 as a prognostic factor in laryngeal cancer, Anticancer Res, vol.25, pp.1115-1121

A. Farioli, F. S. Violante, S. Mattioli, S. Curti, and D. Kriebel, Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database, Cancer Causes Control, vol.24, pp.1535-1545, 2013.

E. Fass, E. Shvets, I. Degani, K. Hirschberg, and Z. Elazar, Microtubules Support Production of Starvation-induced Autophagosomes but Not Their Targeting and Fusion with Lysosomes, J. Biol. Chem, vol.281, pp.36303-36316, 2006.

F. Fausti, S. Di-agostino, A. Sacconi, S. Strano, and G. Blandino, Hippo and rassf1a Pathways: A Growing Affair, 2012.

E. Felley-bosco and R. Stahel, Hippo/YAP pathway for targeted therapy, Transl. Lung Cancer Res, vol.3, p.75, 2014.

S. L. Fenton, A. Dallol, A. Agathanggelou, L. Hesson, J. Ahmed-choudhury et al., Identification of the E1A-Regulated Transcription Factor p120E4F as an Interacting Partner of the RASSF1A Candidate Tumor Suppressor Gene, Cancer Res, vol.64, pp.102-107, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02262407

M. L. Finch-edmondson, R. P. Strauss, J. S. Clayton, G. C. Yeoh, and B. A. Callus, Splice variant insertions in the C-terminus impairs YAP's transactivation domain, Biochem. Biophys. Rep, vol.6, pp.24-31, 2016.

J. R. Fischer, U. Ohnmacht, N. Rieger, M. Zemaitis, C. Stoffregen et al., Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma, Lung Cancer Amst. Neth, vol.54, pp.109-116, 2006.

M. Fischer, P. Rikeit, P. Knaus, and C. Coirault, YAP-Mediated Mechanotransduction in Skeletal Muscle, Front. Physiol, vol.7, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01286654

G. Fontanini, M. De-laurentiis, S. Vignati, S. Chinè, M. Lucchi et al., Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.4, pp.241-249, 1998.

S. A. Fox, A. K. Richards, I. Kusumah, V. Perumal, E. M. Bolitho et al., Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells, Biochem. Biophys. Res. Commun, vol.440, pp.82-87, 2013.

T. Frebourg, G. Lerebours, B. Delpech, D. Benhamou, P. Bertrand et al., Serum hyaluronate in malignant pleural mesothelioma, Cancer, vol.59, pp.2104-2107, 1987.

M. Fujii, N. Fujimoto, A. Hiraki, K. Gemba, K. Aoe et al., Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma, Cancer Sci, vol.103, pp.510-514, 2012.

N. Fujimoto, K. Gemba, M. Asano, Y. Fuchimoto, S. Wada et al., , 2013.

, Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma, Respir. Investig, vol.51, pp.92-97

S. Fukuda, H. Nishida-fukuda, H. Nakayama, H. Inoue, and S. Higashiyama, Monoubiquitination of pro-amphiregulin regulates its endocytosis and ectodomain shedding, Biochem. Biophys. Res. Commun, vol.420, pp.315-320, 2012.

N. Furth, A. , and Y. , The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway, Cell Death Differ, vol.24, 1488.

C. J. Gaffney, T. Oka, V. Mazack, D. Hilman, U. Gat et al., Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene, Gene, vol.509, pp.215-222, 2012.

J. A. Galan, A. , and J. , MST1/MST2 Protein Kinases: Regulation and Physiologic Roles, Biochemistry (Mosc.), vol.55, pp.5507-5519, 2016.

R. K. Gandhirajan, M. Jain, B. Walla, M. Johnsen, M. P. Bartram et al., Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ), J. Biol. Chem, vol.291, pp.11596-11607, 2016.

J. Gao, C. H. Ulekleiv, and T. S. Halstensen, Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGFinduced amphiregulin expression, J. Exp. Clin. Cancer Res. CR, vol.35, 2016.

R. Ge, E. Tan, S. Sharghi-namini, and H. H. Asada, Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers? Cancer Microenviron, vol.5, pp.323-332, 2012.

A. Genevet, M. C. Wehr, R. Brain, B. J. Thompson, and N. Tapon, Kibra Is a Regulator of the Salvador/Warts/Hippo Signaling Network, Dev. Cell, vol.18, pp.300-308, 2010.

H. A. Ghazaleh, R. S. Chow, S. L. Choo, D. Pham, J. D. Olesen et al., 14-3-3 mediated regulation of the tumor suppressor protein, RASSF1A, Apoptosis Int. J. Program. Cell Death, vol.15, pp.117-127, 2010.

C. Gilham, C. Rake, G. Burdett, A. G. Nicholson, L. Davison et al., Original article: Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden, Occup. Environ. Med, vol.73, p.290, 2016.

M. Gloerich, J. P. Klooster, M. J. Vliem, T. Koorman, F. J. Zwartkruis et al., Rap2A links intestinal cell polarity to brush border formation, Nat. Cell Biol, vol.14, pp.793-801, 2012.

S. Goldberg, R. , and G. , Modélisation de l'évolution de la mortalité par mésothéliome de la plèvre en France. Proj. À Horiz, 2012.

M. Gomez, V. Gomez, and A. Hergovich, The Hippo pathway in disease and therapy: cancer and beyond, Clin. Transl. Med, vol.3, p.22, 2014.

S. Goodison, V. Urquidi, and D. Tarin, CD44 cell adhesion molecules, Mol. Pathol, vol.52, pp.189-196, 1999.
DOI : 10.1136/mp.52.4.189

URL : https://mp.bmj.com/content/molpath/52/4/189.full.pdf

J. E. Goodman, M. A. Nascarella, and P. A. Valberg, Ionizing radiation: a risk factor for mesothelioma, Cancer Causes Control CCC, vol.20, pp.1237-1254, 2009.

J. D. Graves, Y. Gotoh, K. E. Draves, D. Ambrose, D. K. Han et al., Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1, EMBO J, vol.17, pp.2224-2234, 1998.

H. Greim, M. J. Utell, L. D. Maxim, and R. Niebo, Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers, Inhal. Toxicol, vol.26, pp.789-810, 2014.

A. Gschwind, S. Hart, O. M. Fischer, and A. Ullrich, TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells, EMBO J, vol.22, pp.2411-2421, 2003.

B. M. Gumbiner and N. Kim, The Hippo-YAP signaling pathway and contact inhibition of growth, J. Cell Sci, vol.127, pp.709-717, 2014.

R. Gundogdu and A. Hergovich, The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell Cycle and DNA Damage Signaling, J. Cell Signal, vol.1, 2016.

L. Guo and L. Teng, YAP/TAZ for cancer therapy: Opportunities and challenges (Review), Int. J. Oncol, vol.46, pp.1444-1452, 2015.

C. Guo, S. Tommasi, L. Liu, J. Yee, R. Dammann et al., RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network, Curr. Biol. CB, vol.17, pp.700-705, 2007.

C. Guo, X. Zhang, and G. P. Pfeifer, The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2, J. Biol. Chem, vol.286, pp.6253-6261, 2011.

G. Guo, J. Chmielecki, C. Goparaju, A. Heguy, I. Dolgalev et al., Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma, Cancer Res, vol.75, pp.264-269, 2015.

S. Gupta, M. Govindaraghavan, and D. Mccollum, Cross Talk between NDR Kinase Pathways Coordinates Cytokinesis with Cell Separation in Schizosaccharomyces pombe, Eukaryot. Cell, vol.13, pp.1104-1112, 2014.

S. Habbig, M. P. Bartram, R. U. Müller, R. Schwarz, N. Andriopoulos et al., NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway, J. Cell Biol, vol.193, pp.633-642, 2011.

S. Halpain and L. Dehmelt, The MAP1 family of microtubule-associated proteins, Genome Biol, vol.7, p.224, 2006.

T. Hanagiri, S. Shinohara, M. Takenaka, Y. Shigematsu, M. Yasuda et al., Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma, Tumor Biol, vol.33, pp.2135-2141, 2012.

M. Hartmann, L. M. Parra, A. Ruschel, S. Böhme, Y. Li et al., , 2015.

, Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44, Mol. Cancer Res, vol.13, pp.879-890

S. Hata, J. Hirayama, H. Kajiho, K. Nakagawa, Y. Hata et al., A Novel Acetylation Cycle of Transcription Co-activator Yes-associated Protein That Is Downstream of Hippo Pathway Is Triggered in Response to S N 2 Alkylating Agents, J. Biol. Chem, vol.287, pp.22089-22098, 2012.

L. Hebert, D. Bellanger, C. Guillas, A. Campagne, F. Dingli et al., Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function, Oncotarget, vol.8, p.72513, 2017.

A. Hergovich, MOB control: Reviewing a conserved family of kinase regulators, Cell. Signal, vol.23, pp.1433-1440, 2011.

A. Hergovich, Mammalian Hippo signalling: a kinase network regulated by protein-protein interactions: Figure 1, Biochem. Soc. Trans, vol.40, pp.124-128, 2012.

A. Hergovich, Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling, Cell Biosci, vol.3, p.32, 2013.

A. Hergovich and B. A. Hemmings, Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways, Semin. Cell Dev. Biol, vol.23, pp.794-802, 2012.

A. Hergovich, R. S. Kohler, D. Schmitz, A. Vichalkovski, H. Cornils et al., The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation, Curr. Biol. CB, vol.19, pp.1692-1702, 2009.

L. Hesson, I. Bièche, D. Krex, E. Criniere, K. Hoang-xuan et al., Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas, Oncogene, vol.23, pp.2408-2419, 2004.

L. B. Hesson, R. Wilson, D. Morton, C. Adams, M. Walker et al., CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations, Oncogene, vol.24, pp.3987-3994, 2005.

J. N. Higginbotham, M. D. Beckler, J. D. Gephart, J. L. Franklin, G. Bogatcheva et al., Amphiregulin exosomes increase cancer cell invasion, Curr. Biol. CB, vol.21, pp.779-786, 2011.

D. Hilman and U. Gat, The evolutionary history of YAP and the hippo/YAP pathway, Mol. Biol. Evol, vol.28, pp.2403-2417, 2011.

T. Hirota, T. Morisaki, Y. Nishiyama, T. Marumoto, K. Tada et al., Zyxin, a Regulator of Actin Filament Assembly, Targets the Mitotic Apparatus by Interacting with H-Warts/Lats1 Tumor Suppressor, J. Cell Biol, vol.149, pp.1073-1086, 2000.

S. Hobor, B. O. Van-emburgh, E. Crowley, S. Misale, F. Di-nicolantonio et al., TGF and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells, Clin. Cancer Res, vol.20, pp.6429-6438, 2014.

D. C. Hodgson, E. S. Gilbert, G. M. Dores, S. J. Schonfeld, C. F. Lynch et al., Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.1489-1497, 2007.

J. T. Hodgson, D. M. Mcelvenny, A. J. Darnton, M. J. Price, and J. Peto, The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050, Br. J. Cancer, vol.92, pp.587-593, 2005.

W. Hong and K. Guan, The YAP and TAZ transcription coactivators: key downstream effectors of the mammalian Hippo pathway, Semin. Cell Dev. Biol, vol.23, pp.785-793, 2012.

X. Hong, H. T. Nguyen, Q. Chen, R. Zhang, Z. Hagman et al., Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover, EMBO J, vol.33, pp.2447-2457, 2014.

S. Hopkins-donaldson, L. L. Belyanskaya, A. P. Simões-wüst, B. Sigrist, S. Kurtz et al., p53-Induced Apoptosis Occurs in the Absence of p14ARF in Malignant Pleural Mesothelioma, vol.8, pp.551-559, 2006.

P. Hsu, B. You, Y. Yang, W. Zhang, Y. Wang et al., YAP promotes erlotinib resistance in human non-small cell lung cancer cells, Oncotarget, vol.7, pp.51922-51933, 2016.

S. X. Huang, M. Jaurand, D. W. Kamp, J. Whysner, and T. K. Hei, Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases, J. Toxicol. Environ. Health Part B, vol.14, pp.179-245, 2011.

W. Huang, X. Lv, C. Liu, Z. Zha, H. Zhang et al., The Nterminal Phosphodegron Targets TAZ/WWTR1 Protein for SCF?-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition, J. Biol. Chem, vol.287, pp.26245-26253, 2012.

J. W. Huh, H. R. Kim, Y. J. Kim, J. H. Lee, Y. S. Park et al., Expression of standard CD44 in human colorectal carcinoma: Association with prognosis, Pathol. Int, vol.59, pp.241-246, 2009.

Y. Huo, H. Cai, I. Teplova, C. Bowman-colin, G. Chen et al., Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer, Cancer Discov, vol.3, pp.894-907, 2013.

A. Hurbin, L. Dubrez, J. Coll, and M. Favrot, Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell Lines, J. Biol. Chem, vol.277, pp.49127-49133, 2002.

A. Hurbin, J. Coll, L. Dubrez-daloz, B. Mari, P. Auberger et al., Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax-and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells, J. Biol. Chem, vol.280, pp.19757-19767, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00340599

A. N. Husain, T. Colby, N. Ordonez, T. Krausz, R. Attanoos et al., Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group, Arch. Pathol. Lab. Med, vol.137, pp.647-667, 2013.

E. Hwang, K. Ryu, K. Pääkkönen, P. Güntert, H. Cheong et al., Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.9236-9241, 2007.

M. Hylebos, G. Van-camp, J. P. Van-meerbeeck, and K. Op-de-beeck, The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing, J. Thorac. Oncol, vol.11, pp.1615-1626, 2016.

I. Hysi, H. Porte, A. Renier, F. Le-pimpec-barthes, A. Scherpereel et al., Classification moléculaire des mésothéliomes en sousgroupes tumoraux, Chir. Thorac. Cardio-Vasc, vol.18, pp.225-229, 2014.

. Inai, Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma, Oncol. Rep, vol.24, 2010.

N. Ishikawa, Y. Daigo, A. Takano, M. Taniwaki, T. Kato et al., Increases of Amphiregulin and Transforming Growth Factor-? in Serum as Predictors of Poor Response to Gefitinib among Patients with Advanced Non-Small Cell Lung Cancers, Cancer Res, vol.65, pp.9176-9184, 2005.

M. Isokane, M. Hieda, S. Hirakawa, M. Shudou, K. Nakashiro et al., Plasma-membrane-anchored growth factor pro-amphiregulin binds A-type lamin and regulates global transcription, J Cell Sci, vol.121, pp.3608-3618, 2008.

B. Jacobs, W. De-roock, H. Piessevaux, R. Van-oirbeek, B. Biesmans et al., Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.27, pp.5068-5074, 2009.

R. Jagadeeswaran, P. C. Ma, T. Y. Seiwert, S. Jagadeeswaran, O. Zumba et al., Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma, Cancer Res, vol.66, pp.352-361, 2006.

R. Jagannathan, G. V. Schimizzi, K. Zhang, A. J. Loza, N. Yabuta et al., , 2016.

, AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol, Mol. Cell. Biol, vol.36, pp.2526-2542

A. M. Jamieson, L. Pasman, S. Yu, P. Gamradt, R. J. Homer et al., Role of tissue protection in lethal respiratory viral-bacterial coinfection, Science, vol.340, pp.1230-1234, 2013.

S. Jang, S. Yang, S. Srinivasan, Y. , and K. , Akt Phosphorylates MstI and Prevents Its Proteolytic Activation, Blocking FOXO3 Phosphorylation and Nuclear Translocation, J. Biol. Chem, vol.282, pp.30836-30844, 2007.
DOI : 10.1074/jbc.m704542200

URL : http://www.jbc.org/content/282/42/30836.full.pdf

H. J. Janse-van-rensburg, Y. , and X. , The roles of the Hippo pathway in cancer metastasis, Cell. Signal, vol.28, pp.1761-1772, 2016.

D. Jean, J. Daubriac, F. Le-pimpec-barthes, F. Galateau-salle, and M. Jaurand, Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment, Arch. Pathol. Lab. Med, vol.136, pp.277-293, 2012.

C. Jing, Y. H. Jin, Z. You, Q. Qiong, J. et al., Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients, Oncotarget, vol.7, pp.55890-55899, 2016.

F. Jing, H. J. Kim, C. H. Kim, Y. J. Kim, J. H. Lee et al., Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases, Int. J. Oncol, vol.46, pp.1582-1588, 2015.

C. Joffre, N. Dupont, L. Hoa, V. Gomez, R. Pardo et al., The Pro-apoptotic STK38 Kinase Is a New Beclin1 Partner Positively Regulating Autophagy, vol.25, pp.2479-2492, 2015.

R. Johnson and G. Halder, The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment, Nat. Rev. Drug Discov, vol.13, p.63, 2014.

G. R. Johnson, T. Saeki, N. Auersperg, A. W. Gordon, M. Shoyab et al., , 1991.

, Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: Nuclear localization of endogenous amphiregulin, Biochem. Biophys. Res. Commun, vol.180, pp.481-488

S. Jung, J. G. Kang, J. H. Lee, K. J. Song, J. H. Ko et al., PHLPP1 regulates contact inhibition by dephosphorylating Mst1 at the inhibitory site, Biochem. Biophys. Res. Commun, vol.443, pp.1263-1269, 2014.

H. Y. Kaan, S. W. Chan, S. K. Tan, F. Guo, C. J. Lim et al., Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex, 2017.

K. Kadota, K. Suzuki, C. Colovos, C. S. Sima, V. W. Rusch et al., A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.25, pp.260-271, 2012.

H. C. Kang, H. K. Kim, S. Lee, P. Mendez, J. W. Kim et al., Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas, Oncotarget, vol.7, pp.8321-8331, 2016.

S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder, Autocrine Extracellular Signal-regulated Kinase (ERK) Activation in Normal Human Keratinocytes: Metalloproteinase-mediated Release of Amphiregulin Triggers Signaling from ErbB1 to ERK, Mol. Biol. Cell, vol.15, pp.4299-4309, 2004.

K. Katagiri, T. Katakai, Y. Ebisuno, Y. Ueda, T. Okada et al., Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes, EMBO J, vol.28, pp.1319-1331, 2009.
DOI : 10.1038/emboj.2009.82

URL : http://emboj.embopress.org/content/28/9/1319.full.pdf

K. Kawaguchi, H. Murakami, T. Taniguchi, M. Fujii, S. Kawata et al., Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells, Carcinogenesis, vol.30, pp.1097-1105, 2009.

S. Khambata-ford, C. R. Garrett, N. J. Meropol, M. Basik, C. T. Harbison et al., Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.3230-3237, 2007.

N. Kim and B. M. Gumbiner, Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway, J Cell Biol, vol.210, pp.503-515, 2015.

S. Kim, D. Lim, C. E. Canman, and M. B. Kastan, Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members, J. Biol. Chem, vol.274, pp.37538-37543, 1999.

S. Kim, Y. Tachioka, T. Mori, and T. Hakoshima, Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway, Sci. Rep, vol.6, 2016.

T. Kim, S. Yang, D. Hwang, J. Song, M. Kim et al., A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness, Nat. Commun, vol.6, 2015.

N. De-klerk, H. Alfonso, N. Olsen, A. Reid, J. Sleith et al., Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia, Int. J. Cancer, vol.132, pp.1423-1428, 2013.

R. Köchl, X. W. Hu, E. Y. Chan, and S. A. Tooze, Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes, Traffic Cph. Den, vol.7, pp.129-145, 2006.

R. S. Kohler, D. Schmitz, H. Cornils, B. A. Hemmings, and A. Hergovich, Differential NDR/LATS Interactions with the Human MOB Family Reveal a Negative Role for Human MOB2 in the Regulation of Human NDR Kinases, Mol. Cell. Biol, vol.30, pp.4507-4520, 2010.

S. Kumar-singh, J. Weyler, M. J. Martin, P. B. Vermeulen, and E. Van-marck, Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression, J. Pathol, vol.189, pp.72-78, 1999.

M. Ladanyi, M. G. Zauderer, L. M. Krug, T. Ito, R. Mcmillan et al., New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.18, pp.4485-4490, 2012.

L. M. Lafave, W. Béguelin, R. Koche, M. Teater, B. Spitzer et al., Loss of BAP1 function leads to EZH2-dependent transformation, Nat. Med, vol.21, pp.1344-1349, 2015.

D. Lallemand, NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions, Genes Dev, vol.17, pp.1090-1100, 2003.

E. P. Lamber, A. A. Horwitz, and J. D. Parvin, BRCA1 represses Amphiregulin gene expression, Cancer Res, vol.70, pp.996-1005, 2010.

E. Lapi, S. Di-agostino, S. Donzelli, H. Gal, E. Domany et al., PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop, Mol. Cell, vol.32, pp.803-814, 2008.

L. Stang, N. Belot, A. Gilg-soit-ilg, A. Rolland, P. Astoul et al., Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005: Evolution of Pleural Cancers in France, Int. J. Cancer, vol.126, pp.232-238, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00421609

A. Y. Lee, D. J. Raz, B. He, and D. M. Jablons, Update on the molecular biology of malignant mesothelioma, Cancer, vol.109, pp.1454-1461, 2007.

K. Lee, T. Ohyama, N. Yajima, S. Tsubuki, Y. et al., MST, a Physiological Caspase Substrate, Highly Sensitizes Apoptosis Both Upstream and Downstream of Caspase Activation, J. Biol. Chem, vol.276, pp.19276-19285, 2001.

M. Lee, S. Jeong, K. Ko, S. Park, B. Ryu et al., , 2016.

, RASSF1A Directly Antagonizes RhoA Activity through the Assembly of a Smurf1-Mediated Destruction Complex to Suppress Tumorigenesis, Cancer Res, vol.76, pp.1847-1859

M. K. Lehtinen, Z. Yuan, P. R. Boag, Y. Yang, J. Villén et al., A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span, Cell, vol.125, pp.987-1001, 2006.

G. Levallet, M. Vaisse-lesteven, N. L. Stang, A. G. Ilg, P. Brochard et al., Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group, J. Thorac. Oncol, vol.7, pp.599-606, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01853402

K. S. Levano and P. A. Kenny, Clarification of the C-terminal proteolytic processing site of human Amphiregulin, FEBS Lett, vol.586, pp.3500-3502, 2012.

P. A. Levin and J. E. Dowell, Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date, OncoTargets Ther, vol.10, pp.2057-2066, 2017.

B. Levine and D. J. Klionsky, Development by self-digestion: molecular mechanisms and biological functions of autophagy, Dev. Cell, vol.6, pp.463-477, 2004.

D. Levy, Y. Adamovich, N. Reuven, and Y. Shaul, Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage, Mol. Cell, vol.29, pp.350-361, 2008.

X. Li, F. , and H. , Loss of Ectodomain Shedding Due to Mutations in the Metalloprotease and Cysteinerich/Disintegrin Domains of the Tumor Necrosis Factor-? Converting Enzyme (TACE), J. Biol. Chem, vol.279, pp.27365-27375, 2004.

C. Li, H. Lu, J. Hu, J. Lan, N. Galicia et al., ?E-catenin inhibits YAP/TAZ activity to regulate signalling centre formation during tooth development, Nat. Commun, vol.7, p.12133, 2016.

P. Li, M. R. Silvis, Y. Honaker, W. Lien, S. T. Arron et al., ?E-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway, Genes Dev, vol.30, pp.798-811, 2016.

S. Li, G. D. Plowman, S. D. Buckley, and G. D. Shipley, Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells, J. Cell. Physiol, vol.153, pp.103-111, 1992.

X. Li, X. Ma, L. Chen, L. Gu, Y. Zhang et al., , 2015.

, Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis, Sci. Rep, vol.5

X. Li, S. Miao, G. Wang, L. Yang, Y. Shu et al., Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics, Oncol. Res. Treat, vol.33, pp.353-358, 2010.

Y. Li, H. Zhou, F. Li, S. W. Chan, Z. Lin et al., , 2015.

, Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway, Cell Res, vol.25, pp.801-817

L. Lin, A. J. Sabnis, E. Chan, V. Olivas, L. Cade et al., The Hippo effector YAP promotes resistance to RAF-and MEK-targeted cancer therapies, Nat. Genet, vol.47, pp.250-256, 2015.

X. Lin, F. Cai, X. Li, X. Kong, C. Xu et al., Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer, Tumor Biol, vol.34, pp.3239-3243, 2013.

Y. Lin, A. Khokhlatchev, D. Figeys, A. , and J. , Death-associated Protein 4 Binds MST1 and Augments MST1-induced Apoptosis, J. Biol. Chem, vol.277, pp.47991-48001, 2002.

D. Lindquist, A. Ahrlund-richter, M. Tarján, T. Tot, and T. Dalianis, Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer, Anticancer Res, vol.32, pp.153-161, 2012.

Z. Liu and J. Klominek, Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors, Thorax, vol.58, pp.198-203, 2003.

Z. Liu and J. Klominek, Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors, Anticancer Res, vol.24, pp.1625-1630, 2004.

C. Liu, Z. Zha, X. Zhou, H. Zhang, W. Huang et al.,

, The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCF?-TrCP E3 Ligase, J. Biol. Chem, vol.285, pp.37159-37169

L. Liu, S. Tommasi, D. Lee, R. Dammann, and G. P. Pfeifer, Control of microtubule stability by the RASSF1A tumor suppressor, Oncogene, vol.22, pp.8125-8136, 2003.

M. Lo-iacono, V. Monica, L. Righi, F. Grosso, R. Libener et al., Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study, J. Thorac. Oncol, vol.10, pp.492-499, 2015.

F. López-ríos, P. B. Illei, V. Rusch, and M. Ladanyi, Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids, The Lancet, vol.364, pp.1157-1166, 2004.

X. Luo, Z. Li, Q. Yan, X. Li, D. Tao et al., The human WW45 protein enhances MST1-mediated apoptosis in vivo, Int. J. Mol. Med, vol.23, pp.357-362, 2009.

X. Lv, C. Liu, Z. Wang, Y. Sun, Y. Xiong et al., PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction, EMBO Rep, vol.16, pp.975-985, 2015.

X. Ma, H. Zhang, X. Xue, and Y. M. Shah, Hypoxia-inducible factor 2? (HIF-2?) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity, J. Biol. Chem, vol.292, pp.17046-17056, 2017.

Y. Maejima, S. Kyoi, P. Zhai, T. Liu, H. Li et al., Mst1 inhibits autophagy by promoting Beclin1-Bcl-2 interaction, Nat. Med, vol.19, pp.1478-1488, 2013.

X. Mao, P. Li, Y. Wang, Z. Liang, J. Liu et al., CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells, Cell Death Dis, vol.8, p.2546, 2017.

A. Marinaccio, A. Binazzi, G. Cauzillo, D. Cavone, R. D. Zotti et al., Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register, Eur. J. Cancer Oxf. Engl, vol.43, pp.2722-2728, 1990.

G. Martensson, A. Thylen, U. Lindquist, and A. Hjerpe, The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods, Cancer, vol.73, pp.1406-1410, 1994.

K. Masago, S. Fujita, Y. Hatachi, A. Fukuhara, K. Sakuma et al., Clinical significance of pretreatment serum amphiregulin and transforming growth factor-?, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer, Cancer Sci, vol.99, pp.2295-2301, 2008.

D. Matallanas, D. Romano, K. Yee, K. Meissl, L. Kucerova et al., RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor Protein, Mol. Cell, vol.27, pp.962-975, 2007.

E. Máthé, RASSF1A, the new guardian of mitosis, Nat. Genet, vol.36, pp.117-118, 2004.

M. Matsui, J. Miyasaka, K. Hamada, Y. Ogawa, M. Hiramoto et al., Influence of aging and cell senescence on telomerase activity in keratinocytes, J. Dermatol. Sci, vol.22, pp.80-87, 2000.

G. Matullo, S. Guarrera, M. Betti, G. Fiorito, D. Ferrante et al., Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study, PLoS ONE, vol.8, 2013.

A. Mauviel, F. Nallet-staub, and X. Varelas, Integrating developmental signals: a Hippo in the (path)way, Oncogene, vol.31, pp.1743-1756, 2012.

M. Meerang, K. Bérard, M. Friess, B. K. Bitanihirwe, A. Soltermann et al., Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma, Mol. Oncol, vol.10, pp.1255-1265, 2016.

S. Menashi, M. Serova, L. Ma, S. Vignot, S. Mourah et al., Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells, Cancer Res, vol.63, pp.7575-7580, 2003.

Z. Meng, T. Moroishi, V. Mottier-pavie, S. W. Plouffe, C. G. Hansen et al., MAP4K family kinases, vol.6, p.8357, 2015.

Z. Meng, T. Moroishi, and K. Guan, Mechanisms of Hippo pathway regulation, Genes Dev, vol.30, pp.1-17, 2016.

S. Metintas, M. Metintas, I. Ucgun, and U. Oner, Malignant Mesothelioma due to Environmental Exposure to Asbestos, Chest, vol.122, pp.2224-2229, 2002.

C. Metz-flamant, I. Guseva-canu, and D. Laurier, Malignant pleural mesothelioma risk among nuclear workers: a review, J. Radiol. Prot. Off. J. Soc. Radiol. Prot, vol.31, pp.9-23, 2011.

C. Meulenbroeks, H. Weelden, . Van, C. Schwartz, D. Voehringer et al., Basophil-Derived Amphiregulin Is Essential for UVB Irradiation-Induced Immune Suppression, J. Invest. Dermatol, vol.135, pp.222-228, 2015.

R. Mezzapelle, U. Miglio, O. Rena, A. Paganotti, S. Allegrini et al., Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma, Br. J. Cancer, vol.108, pp.1743-1749, 2013.

W. Mi, Q. Lin, C. Childress, M. Sudol, J. Robishaw et al., , 2015.

, Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration, Oncogene, vol.34, p.3095

C. Michaloglou, W. Lehmann, T. Martin, C. Delaunay, A. Hueber et al., The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity, PLoS ONE, vol.8, 2013.

U. Michgehl, H. Pavenstädt, and B. Vollenbröker, Cross talk between the Crumbs complex and Hippo signaling in renal epithelial cells. Pflüg. Arch. -Eur, J. Physiol, vol.469, pp.917-926, 2017.

K. E. Miletti-gonzález, K. Murphy, M. N. Kumaran, A. K. Ravindranath, R. P. Wernyj et al., Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD), J. Biol. Chem, vol.287, pp.18995-19007, 2012.

P. Minoo, I. Zlobec, K. Baker, L. Tornillo, L. Terracciano et al., Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer, Mod. Pathol, vol.20, pp.331-338, 2007.

E. Miozzi, V. Rapisarda, A. Marconi, C. Costa, I. Polito et al., , 2015.

-. Fluoro, The health impact of 'asbestos-like' fibres (Review), Exp. Ther. Med

S. Misra, S. Ghatak, and B. P. Toole, Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2, J. Biol. Chem, vol.280, pp.20310-20315, 2005.

S. K. Mitra and D. D. Schlaepfer, Integrin-regulated FAK-Src signaling in normal and cancer cells, Curr. Opin. Cell Biol, vol.18, pp.516-523, 2006.

A. Miyanaga, M. Masuda, K. Tsuta, K. Kawasaki, Y. Nakamura et al., Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing, J. Thorac. Oncol, vol.10, pp.844-851, 2015.

J. Mo, Z. Meng, Y. C. Kim, H. W. Park, C. G. Hansen et al., Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway, Nat. Cell Biol, vol.17, pp.500-510, 2015.

L. A. Monticelli, G. F. Sonnenberg, M. C. Abt, T. Alenghat, C. G. Ziegler et al., Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection, Nat. Immunol, vol.12, pp.1045-1054, 2011.

T. Moroishi, H. W. Park, B. Qin, Q. Chen, Z. Meng et al., A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis, Genes Dev, vol.29, pp.1271-1284, 2015.

H. Morrison, L. S. Sherman, J. Legg, F. Banine, C. Isacke et al., The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44, Genes Dev, vol.15, pp.968-980, 2001.

H. Murakami, T. Mizuno, T. Taniguchi, M. Fujii, F. Ishiguro et al., LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma, Cancer Res, vol.71, pp.873-883, 2011.

G. Murphy, Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases, Semin. Cell Dev. Biol, vol.20, pp.138-145, 2009.

O. Nagano and H. Saya, Mechanism and biological significance of CD44 cleavage, Cancer Sci, vol.95, pp.930-935, 2004.

M. Nakamura, P. Zhai, D. P. Del-re, Y. Maejima, and J. Sadoshima, Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury, JCI Insight, vol.1, 2016.

F. Nallet-staub, V. Marsaud, L. Li, C. Gilbert, S. Dodier et al., Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma, J. Invest. Dermatol, vol.134, pp.123-132, 2014.

D. Naor, R. V. Sionov, and D. Ish-shalom, CD44: structure, function, and association with the malignant process, Adv. Cancer Res, vol.71, pp.241-319, 1997.

N. T. Nehme, J. P. Schmid, F. Debeurme, I. André-schmutz, A. Lim et al., MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival, Blood, vol.119, pp.3458-3468, 2012.

D. B. Nelson, D. C. Rice, J. Niu, S. Atay, A. A. Vaporciyan et al., Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.35, pp.3354-3362, 2017.

H. B. Nguyen, J. T. Babcock, C. D. Wells, and L. A. Quilliam, LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap, Oncogene, vol.32, pp.4100-4109, 2013.

L. Ni, Y. Zheng, M. Hara, D. Pan, and X. Luo, Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling, Genes Dev, vol.29, pp.1416-1431, 2015.

E. Nishi, Y. Hiraoka, K. Yoshida, K. Okawa, and T. Kita, Nardilysin Enhances Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor through Activation of Tumor Necrosis Factor-?-converting Enzyme, J. Biol. Chem, vol.281, pp.31164-31172, 2006.

A. K. Nowak, K. Chansky, D. C. Rice, H. I. Pass, H. L. Kindler et al., The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma, J. Thorac. Oncol, vol.11, pp.2089-2099, 2016.

B. Nuvoli, S. Germoni, C. Morosetti, R. Santoro, G. Cortese et al., , 2014.

, Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease, Mol. Cancer, vol.13, p.69

H. J. Oh, K. Lee, S. J. Song, M. S. Jin, M. S. Song et al., Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis, Cancer Res, vol.66, pp.2562-2569, 2006.

H. J. Oh, M. J. Kim, S. J. Song, T. Kim, D. Lee et al., MST1 Limits the Kinase Activity of Aurora B to Promote Stable Kinetochore-Microtubule Attachment, Curr. Biol, vol.20, pp.416-422, 2010.

J. A. Ohar, M. Cheung, J. Talarchek, S. E. Howard, T. D. Howard et al., Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer, Cancer Res, vol.76, pp.206-215, 2016.

R. Ohashi, F. Takahashi, R. Cui, M. Yoshioka, T. Gu et al., Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell, Cancer Lett, vol.252, pp.225-234, 2007.

T. Ohchi, Y. Akagi, T. Kinugasa, T. Kakuma, A. Kawahara et al., Amphiregulin Is a Prognostic Factor in Colorectal Cancer, Anticancer Res, vol.32, pp.2315-2321, 2012.

T. Oka, V. Mazack, and M. Sudol, Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinaseassociated Protein (YAP), J. Biol. Chem, vol.283, pp.27534-27546, 2008.

T. Oka, E. Remue, K. Meerschaert, B. Vanloo, C. Boucherie et al., Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling, Biochem. J, vol.432, pp.461-472, 2010.

T. Oka, A. P. Schmitt, and M. Sudol, Opposing roles of angiomotin-like-1 and zona occludens-2 on proapoptotic function of YAP, Oncogene, vol.31, pp.128-134, 2012.

I. Okamoto, H. Tsuiki, L. C. Kenyon, A. K. Godwin, D. R. Emlet et al., Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors, Am. J. Pathol, vol.160, pp.441-447, 2002.

I. S. Okoye, S. M. Coomes, V. S. Pelly, S. Czieso, V. Papayannopoulos et al., MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells, Immunity, vol.41, pp.89-103, 2014.

Z. Orbán-németh, H. Simader, S. Badurek, A. Tranciková, and F. Propst, Microtubule-associated protein 1S, a short and ubiquitously expressed member of the microtubule-associated protein 1 family, J. Biol. Chem, vol.280, pp.2257-2265, 2005.

B. A. Orr, H. Bai, Y. Odia, D. Jain, R. A. Anders et al., Yes-Associated Protein, vol.1, 2011.

, Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth, J. Neuropathol. Exp. Neurol, vol.70, pp.568-577

M. A. Ortega-guerrero, G. Carrasco-núñez, H. Barragán-campos, and M. R. Ortega, High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico, Occup. Environ. Med, vol.72, pp.216-218, 2015.

M. J. Oudhoff, S. A. Freeman, A. L. Couzens, F. Antignano, E. Kuznetsova et al., Control of the Hippo Pathway by Set7-Dependent Methylation of Yap, Dev. Cell, vol.26, pp.188-194, 2013.

D. Pan, YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment, J. Clin. Oncol, vol.33, pp.2311-2313, 2015.

H. I. Pass, M. Bocchetta, and M. Carbone, Evidence of an important role for SV40 in mesothelioma, Thorac. Surg. Clin, vol.14, pp.489-495, 2004.

L. R. Pearce, D. Komander, A. , and D. R. , The nuts and bolts of AGC protein kinases, Nat. Rev. Mol. Cell Biol, vol.11, pp.9-22, 2010.

M. Peng, W. , and H. , Embryology and gross structure, pp.3-16, 2003.

A. Perra, M. A. Kowalik, E. Ghiso, G. M. Ledda-columbano, L. Di-tommaso et al., YAP activation is an early event and a potential therapeutic target in liver cancer development, J. Hepatol, vol.61, pp.1088-1096, 2014.

J. Peto, A. Decarli, C. La-vecchia, F. Levi, and E. Negri, The European mesothelioma epidemic, Br. J. Cancer, vol.79, pp.666-672, 1999.

S. Piccolo, S. Dupont, and M. Cordenonsi, The biology of YAP/TAZ: hippo signaling and beyond, Physiol. Rev, vol.94, pp.1287-1312, 2014.

S. Pijuan-galitó, C. Tamm, A. , and C. , Serum Inter-?-inhibitor Activates the Yes Tyrosine Kinase and YAP/TEAD Transcriptional Complex in Mouse Embryonic Stem Cells, J. Biol. Chem, vol.289, pp.33492-33502, 2014.

R. Pillappa, J. J. Maleszewski, W. R. Sukov, P. P. Bedroske, P. T. Greipp et al., Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma, Am. J. Surg. Pathol, vol.1, 2017.

S. W. Plouffe, Z. Meng, K. C. Lin, B. Lin, A. W. Hong et al., Characterization of Hippo Pathway Components by Gene Inactivation, Mol. Cell, vol.64, pp.993-1008, 2016.

G. D. Plowman, J. M. Green, V. L. Mcdonald, M. G. Neubauer, C. M. Disteche et al., The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity, Mol. Cell. Biol, vol.10, pp.1969-1981, 1990.

H. Ponta, L. Sherman, and P. A. Herrlich, CD44: From adhesion molecules to signalling regulators, Nat. Rev. Mol. Cell Biol, vol.4, p.33, 2003.

C. L. Poon, J. I. Lin, X. Zhang, and K. F. Harvey, The Sterile 20-like Kinase Tao-1 Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway, Dev. Cell, vol.21, pp.896-906, 2011.

P. I. Poulikakos, G. Xiao, R. Gallagher, S. Jablonski, S. C. Jhanwar et al., Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK, Oncogene, vol.25, p.5960, 2006.

M. Praskova, F. Xia, A. , and J. , MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation, Curr. Biol. CB, vol.18, pp.311-321, 2008.
DOI : 10.1016/j.cub.2008.02.006

URL : https://doi.org/10.1016/j.cub.2008.02.006

C. Preisinger, B. Short, V. De-corte, E. Bruyneel, A. Haas et al., YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3?, J. Cell Biol, vol.164, pp.1009-1020, 2004.

L. Qin, J. Tamasi, L. Raggatt, X. Li, J. H. Feyen et al.,

, Amphiregulin Is a Novel Growth Factor Involved in Normal Bone Development and in the Cellular Response to Parathyroid Hormone Stimulation, J. Biol. Chem, vol.280, pp.3974-3981

S. Rabizadeh, R. J. Xavier, K. Ishiguro, J. Bernabeortiz, M. Lopez-ilasaca et al., The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death, J. Biol. Chem, vol.279, pp.29247-29254, 2004.

S. J. Rawat and J. Chernoff, Regulation of mammalian Ste20 (Mst) kinases, Trends Biochem. Sci, vol.40, pp.149-156, 2015.

M. E. Reeves, S. W. Baldwin, M. L. Baldwin, S. Chen, J. M. Moretz et al., Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis, BMC Cancer, vol.10, 2010.

E. Remue, K. Meerschaert, T. Oka, C. Boucherie, J. Vandekerckhove et al., TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner, FEBS Lett, vol.584, pp.4175-4180, 2010.

D. Rice, K. Chansky, A. Nowak, H. Pass, H. Kindler et al., The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.11, pp.2100-2111, 2016.

A. M. Richter, G. P. Pfeifer, and R. H. Dammann, The RASSF proteins in cancer; from epigenetic silencing to functional characterization, Biochim. Biophys. Acta BBA -Rev. Cancer, vol.1796, pp.114-128, 2009.

B. M. Robinson, Malignant pleural mesothelioma: an epidemiological perspective, Ann. Cardiothorac. Surg, vol.1, p.491, 2012.

K. D. Rodland, N. Bollinger, D. Ippolito, L. K. Opresko, R. J. Coffey et al., , 2008.

, Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells, J. Biol. Chem, vol.283, p.31477

S. J. Rogers, C. Box, P. Chambers, Y. Barbachano, C. M. Nutting et al., Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck, J. Pathol, vol.218, pp.122-130, 2009.

J. Rosenbluh, D. Nijhawan, A. G. Cox, X. Li, J. T. Neal et al., ?-catenin driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis, Cell, vol.151, pp.1457-1473, 2012.
DOI : 10.1016/j.cell.2013.03.007

URL : https://doi.org/10.1016/j.cell.2013.03.007

P. Royston and W. Sauerbrei, A new measure of prognostic separation in survival data, Stat. Med, vol.23, pp.723-748, 2004.

P. Ruffié, M. , and J. , Cancer et environnement: le cas de l'amiante, Oncologie, vol.9, pp.335-339, 2007.

V. W. Rusch, K. Chansky, H. L. Kindler, A. K. Nowak, H. I. Pass et al., The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma, vol.11, pp.2112-2119, 2016.

H. Sakurai, E. J. Barros, T. Tsukamoto, J. Barasch, and S. K. Nigam, An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.6279-6284, 1997.

G. Sánchez-sanz, D. Matallanas, L. K. Nguyen, B. N. Kholodenko, E. Rosta et al.,

, MST2-RASSF protein-protein interactions through SARAH domains, Brief. Bioinform, vol.17, pp.593-602

C. D. Santi, O. Melaiu, A. Bonotti, L. Cascione, G. D. Leva et al., Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism, Sci. Rep, vol.7, p.3140, 2017.

U. Schagdarsurengin, O. Gimm, C. Hoang-vu, H. Dralle, G. P. Pfeifer et al., Frequent Epigenetic Silencing of the CpG Island Promoter of RASSF1A in Thyroid Carcinoma, Cancer Res, vol.62, pp.3698-3701, 2002.

A. Scherpereel, The experts' conference of the Société de Pneumologie de Langue Française (SPLF) on malignant pleural mesothelioma (MPM): useful and necessary recommendations, Rev. Mal. Respir, vol.23, pp.11-16, 2006.

A. Scherpereel, Malignant pleural mesothelioma: new treatments, new hopes?, Eur. Respir. J, vol.49, p.1700319, 2017.

V. Schildgen, O. Pabst, R. Tillmann, J. Lüsebrink, O. Schildgen et al., Low frequency of EGFR mutations in pleural mesothelioma patients, Appl. Immunohistochem. Mol. Morphol. AIMM, vol.23, pp.118-125, 2015.

K. Schlegelmilch, M. Mohseni, O. Kirak, J. Pruszak, J. R. Rodriguez et al., Yap1 acts downstream of ?-catenin to control epidermal proliferation, Cell, vol.144, pp.782-795, 2011.

L. Schuger, A. P. Skubitz, K. Gilbride, R. Mandel, and L. He, Laminin and heparan sulfate proteoglycan mediate epithelial cell polarization in organotypic cultures of embryonic lung cells: evidence implicating involvement of the inner globular region of laminin beta 1 chain and the heparan sulfate groups of heparan sulfate proteoglycan, Dev. Biol, vol.179, pp.264-273, 1996.

C. Seidel, U. Schagdarsurengin, K. Blümke, P. Würl, G. P. Pfeifer et al., Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma, Mol. Carcinog, vol.46, pp.865-871, 2007.

Y. Sekido, Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation: Merlin inactivation in mesothelioma, Pathol. Int, vol.61, pp.331-344, 2011.

Y. Sekido, Molecular pathogenesis of malignant mesothelioma, Carcinogenesis, vol.34, pp.1413-1419, 2013.

Y. Sekido, H. I. Pass, S. Bader, D. J. Mew, M. F. Christman et al., Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer, Cancer Res, vol.55, pp.1227-1231, 1995.

C. Servas, S. Kiehlmeier, J. Hach, R. Gross, C. Götz et al., The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2, Cell. Signal, vol.36, pp.163-175, 2017.

L. Shivakumar, J. Minna, T. Sakamaki, R. Pestell, and M. A. White, The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation, Mol. Cell. Biol, vol.22, pp.4309-4318, 2002.

M. Shoyab, G. D. Plowman, V. L. Mcdonald, J. G. Bradley, and G. J. Todaro, Structure and function of human amphiregulin: a member of the epidermal growth factor family, Science, vol.243, pp.1074-1076, 1989.

T. Shukuya, M. Serizawa, M. Watanabe, H. Akamatsu, M. Abe et al., Identification of actionable mutations in malignant pleural mesothelioma, Lung Cancer Amst. Neth, vol.86, pp.35-40, 2014.

M. R. Silvis, B. T. Kreger, W. Lien, O. Klezovitch, G. M. Rudakova et al., ?-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1, Sci. Signal, vol.4, p.33, 2011.

S. Sneddon, J. S. Leon, I. M. Dick, G. Cadby, N. Olsen et al., Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma, Gene, vol.563, pp.103-105, 2015.

W. So, Q. Fan, M. Lau, X. Qiu, J. Cheng et al., Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression, FEBS Lett, vol.588, pp.3998-4007, 2014.

J. Soh, S. Toyooka, S. Ichihara, H. Suehisa, N. Kobayashi et al., EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib, Lung Cancer Amst. Neth, vol.56, pp.445-448, 2007.

B. H. Sohn, J. Shim, S. Kim, K. Y. Jang, S. M. Kim et al., Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma, Clin. Cancer Res, vol.22, pp.1256-1264, 2016.

N. Solic and D. E. Davies, Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells, Exp. Cell Res, vol.234, pp.465-476, 1997.

M. S. Song, S. J. Song, N. G. Ayad, J. S. Chang, J. H. Lee et al., The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex, Nat. Cell Biol, vol.6, pp.129-137, 2004.

M. S. Song, S. J. Song, S. Y. Kim, H. J. Oh, and D. S. Lim, The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex, EMBO J, vol.27, pp.1863-1874, 2008.

S. J. Song, M. S. Song, S. J. Kim, S. Y. Kim, S. H. Kwon et al.,

A. Aurora and . Regulates, Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APCCdc20 Activity, Cancer Res, vol.69, pp.2314-2323

G. Sorrentino, N. Ruggeri, V. Specchia, M. Cordenonsi, M. Mano et al., Metabolic control of YAP and TAZ by the mevalonate pathway, Nat. Cell Biol, vol.16, pp.357-366, 2014.

I. Stamenkovic, Y. , and Q. , Merlin, a "Magic" Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival, Curr. Protein Pept. Sci, vol.11, pp.471-484, 2010.

M. R. Stegert, R. Tamaskovic, S. J. Bichsel, A. Hergovich, and B. A. Hemmings, Regulation of NDR2 Protein Kinase by Multi-site Phosphorylation and the S100B Calcium-binding, Protein. J. Biol. Chem, vol.279, pp.23806-23812, 2004.

M. D. Sternlicht, S. W. Sunnarborg, H. Kouros-mehr, Y. Yu, D. C. Lee et al., Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin, Dev. Camb. Engl, vol.132, p.3923, 2005.

S. W. Stoll, J. L. Johnson, Y. Li, L. Rittié, and J. T. Elder, AMPHIREGULIN CARBOXY-TERMINAL DOMAIN IS REQUIRED FOR AUTOCRINE KERATINOCYTE GROWTH, J. Invest. Dermatol, vol.130, pp.2031-2040, 2010.

L. Strizzi, A. Catalano, G. Vianale, S. Orecchia, A. Casalini et al., Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma, J. Pathol, vol.193, pp.468-475, 2001.

K. N. Sugahara, T. Hirata, H. Hayasaka, R. Stern, T. Murai et al., Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments, J. Biol. Chem, vol.281, pp.5861-5868, 2006.

R. Sumpter and B. Levine, Autophagy and Innate Immunity: Triggering, Targeting and Tuning, Semin. Cell Dev. Biol, vol.21, pp.699-711, 2010.
DOI : 10.1016/j.semcdb.2010.04.003

URL : http://europepmc.org/articles/pmc2930105?pdf=render

N. Taira, T. Yamaguchi, J. Kimura, Z. Lu, S. Fukuda et al., Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.717-722, 2014.

A. Tallet, J. Nault, A. Renier, I. Hysi, F. Galateau-sallé et al., Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma, Oncogene, vol.33, pp.3748-3752, 2014.

I. Tanaka, H. Osada, M. Fujii, A. Fukatsu, T. Hida et al., LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade, Oncogene, vol.34, pp.73-83, 2015.
DOI : 10.1038/onc.2013.528

K. Tanaka, H. Osada, Y. Murakami-tonami, Y. Horio, T. Hida et al., Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis, Cancer Lett, vol.385, pp.215-224, 2017.
DOI : 10.1016/j.canlet.2016.10.020

Y. Tang, R. G. Rowe, E. L. Botvinick, A. Kurup, A. J. Putnam et al., MT1-MMP-Dependent Control of Skeletal Stem Cell Commitment via a ?1-Integrin/YAP/TAZ Signaling Axis, Dev. Cell, vol.25, pp.402-416, 2013.

K. Taniguchi, L. Wu, S. I. Grivennikov, P. R. De-jong, I. Lian et al., A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration, Nature, vol.519, pp.57-62, 2015.
DOI : 10.1038/nature14228

URL : http://europepmc.org/articles/pmc4447318?pdf=render

J. R. Testa, M. Cheung, J. Pei, J. E. Below, Y. Tan et al., Germline BAP1 mutations predispose to malignant mesothelioma, Nat. Genet, vol.43, pp.1022-1025, 2011.

T. Thanh, N. Tho, N. Lam, N. Dung, C. Tabata et al., Simian virus 40 may be associated with developing malignant pleural mesothelioma, Oncol. Lett, 2016.

B. J. Thompson and E. Sahai, MST kinases in development and disease, J Cell Biol, vol.210, pp.871-882, 2015.

C. Thurneysen, I. Opitz, S. Kurtz, W. Weder, R. A. Stahel et al., Functional inactivation of NF2/merlin in human mesothelioma, Lung Cancer, vol.64, pp.140-147, 2009.

V. Tomlinson, K. Gudmundsdottir, P. Luong, K. Leung, A. Knebel et al., JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis, Cell Death Dis, vol.1, p.29, 2010.
DOI : 10.1038/cddis.2010.7

URL : https://www.nature.com/articles/cddis20107.pdf

B. P. Toole, Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.15, pp.7462-7468, 2009.

S. Toyooka, M. Carbone, K. O. Toyooka, M. Bocchetta, N. Shivapurkar et al., Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells, Oncogene, vol.21, pp.4340-4344, 2002.

R. Tranchant, L. Quetel, A. Tallet, C. Meiller, A. Renier et al., Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, Malignant Pleural Mesothelioma. Clin. Cancer Res, vol.23, pp.3191-3202, 2017.

W. D. Travis, E. Brambilla, A. G. Nicholson, Y. Yatabe, J. H. Austin et al., The 2015 World Health Organization Classification of Lung Tumors, J. Thorac. Oncol, vol.10, pp.1243-1260, 2015.

J. Turner, P. J. Morrison, C. Wilhelm, M. Wilson, H. Ahlfors et al., IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation, J. Exp. Med, vol.210, pp.2951-2965, 2013.

X. Varelas, P. Samavarchi-tehrani, M. Narimatsu, A. Weiss, K. Cockburn et al., The Crumbs Complex Couples Cell Density Sensing to Hippo-Dependent Control of the TGF-?-SMAD Pathway, Dev. Cell, vol.19, pp.831-844, 2010.

D. Vavvas, X. Li, J. Avruch, and X. Zhang, Identification of Nore1 as a Potential Ras Effector, J. Biol. Chem, vol.273, pp.5439-5442, 1998.

A. Vichalkovski, E. Gresko, H. Cornils, A. Hergovich, D. Schmitz et al., NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis, Curr. Biol. CB, vol.18, pp.1889-1895, 2008.

S. Visser, Y. , and X. , LATS tumor suppressor: a new governor of cellular homeostasis, Cell Cycle Georget. Tex, vol.9, pp.3892-3903, 2010.

N. Vlahov, S. Scrace, M. S. Soto, A. M. Grawenda, L. Bradley et al., Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion, Curr. Biol, vol.25, pp.3019-3034, 2015.
DOI : 10.1016/j.cub.2015.09.072

URL : https://doi.org/10.1016/j.cub.2015.09.072

N. J. Vogelzang, J. J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel et al., Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.21, pp.2636-2644, 2003.

M. D. Vos, A. Martinez, C. Elam, A. Dallol, B. J. Taylor et al., A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability, Cancer Res, vol.64, pp.4244-4250, 2004.

M. D. Vos, A. Dallol, K. Eckfeld, N. P. Allen, H. Donninger et al., The RASSF1A Tumor Suppressor Activates Bax via MOAP-1, J. Biol. Chem, vol.281, pp.4557-4563, 2006.
DOI : 10.1074/jbc.m512128200

URL : http://www.jbc.org/content/281/8/4557.full.pdf

K. Wada, K. Itoga, T. Okano, S. Yonemura, and H. Sasaki, Hippo pathway regulation by cell morphology and stress fibers, Development, vol.138, pp.3907-3914, 2011.
DOI : 10.1242/dev.070987

URL : http://dev.biologists.org/content/138/18/3907.full.pdf

A. M. Walker, L. D. Maxim, and M. J. Utell, Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity?, Inhal. Toxicol, vol.24, pp.416-424, 2012.

B. Wang, H. Yong, H. Zhu, D. Ni, S. Tang et al., Abnormal amphiregulin expression correlates with gastric cancer prognosis, Oncotarget, vol.7, pp.76684-76692, 2016.

C. Wang, X. Zhu, W. Feng, Y. Yu, K. Jeong et al., Verteporfin inhibits YAP function through up-regulating 14-3-3? sequestering YAP in the cytoplasm, Am. J. Cancer Res, vol.6, p.27, 2016.

H. Wang, Y. Du, X. Zhou, H. Liu, and S. Tang, The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy, Cancer Metastasis Rev, vol.33, pp.173-181, 2014.

J. Wang, J. Sinnett-smith, J. V. Stevens, S. H. Young, and E. Rozengurt, Biphasic Regulation of Yesassociated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells A NOVEL ROLE FOR PROTEIN KINASE D (PKD), J. Biol. Chem, vol.291, pp.17988-18005, 2016.

P. Wang, Y. Bai, B. Song, Y. Wang, D. Liu et al., PP1A-Mediated Dephosphorylation Positively Regulates YAP2 Activity, PLOS ONE, vol.6, 2011.
DOI : 10.1371/journal.pone.0024288

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0024288&type=printable

S. Wang, Y. Zhang, Y. Wang, P. Ye, J. Li et al., Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3?/Foxp3 Axis, J. Biol. Chem, vol.291, pp.21085-21095, 2016.

S. Wang, K. Ma, Q. Wang, F. Sun, Y. Shi et al., The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database, Int. J. Surg, vol.48, pp.92-98, 2017.

W. Wang, J. Huang, X. Wang, J. Yuan, X. Li et al., PTPN14 is required for the density-dependent control of YAP1, Genes Dev, vol.26, pp.1959-1971, 2012.

W. Wang, Z. Xiao, X. Li, K. E. Aziz, B. Gan et al., AMPK modulates Hippo pathway activity to regulate energy homeostasis, Nat. Cell Biol, vol.17, pp.490-499, 2015.
DOI : 10.1038/ncb3113

URL : http://europepmc.org/articles/pmc4380807?pdf=render

W. Wen, F. Zhu, J. Zhang, Y. Keum, T. Zykova et al.,

, MST1 Promotes Apoptosis through Phosphorylation of Histone H2AX, J. Biol. Chem, vol.285, pp.39108-39116

Y. M. Whang, Y. H. Kim, J. S. Kim, and Y. D. Yoo, RASSF1A Suppresses the c-Jun-NH2-Kinase Pathway and Inhibits Cell Cycle Progression, Cancer Res, vol.65, pp.3682-3690, 2005.

P. Wierzbicki and A. Rybarczyk, The Hippo pathway in colorectal cancer, Folia Histochem. Cytobiol. Pol. Acad. Sci. Pol. Histochem. Cytochem. Soc, vol.53, 2015.

D. S. Wilkinson and M. Hansen, LC3 is a novel substrate for the mammalian Hippo kinases, STK3/STK4, Autophagy, vol.11, pp.856-857, 2015.
DOI : 10.1080/15548627.2015.1017197

URL : http://europepmc.org/articles/pmc4509446?pdf=render

D. S. Wilkinson, J. S. Jariwala, E. Anderson, K. Mitra, J. Meisenhelder et al., Phosphorylation of LC3 by the Hippo kinases STK3/STK4 is essential for autophagy, Mol. Cell, vol.57, pp.55-68, 2015.

K. Williams, K. Motiani, P. V. Giridhar, and S. Kasper, CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches, Exp. Biol. Med, vol.238, pp.324-338, 2013.

N. E. Willmarth and S. P. Ethier, Autocrine and Juxtacrine Effects of Amphiregulin on the Proliferative, Invasive, and Migratory Properties of Normal and Neoplastic Human Mammary Epithelial Cells, J. Biol. Chem, vol.281, pp.37728-37737, 2006.

K. E. Wilson, Y. Li, N. Yang, H. Shen, A. R. Orillion et al., PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function, J. Biol. Chem, vol.289, pp.23693-23700, 2014.

K. E. Wilson, N. Yang, A. L. Mussell, and J. Zhang, The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond, Genes, vol.7, 2016.

G. A. Woodard, Y. Yang, L. You, and D. M. Jablons, Drug development against the hippo pathway in mesothelioma, Transl. Lung Cancer Res, vol.6, pp.335-342, 2017.

J. Wu, L. Yin, N. Jiang, W. Guo, J. Gu et al.,

, MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells, Exp. Cell Res, vol.338

Y. Wu, Z. Li, C. Zhang, K. Yu, Z. Teng et al., CD44 family proteins in gastric cancer: a meta-analysis and narrative review, Int. J. Clin. Exp. Med, vol.8, pp.3595-3606, 2015.

L. Xiao, Y. Chen, M. Ji, D. , and J. , KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases, J. Biol. Chem, vol.286, pp.7788-7796, 2011.
DOI : 10.1074/jbc.m110.173468

URL : http://www.jbc.org/content/286/10/7788.full.pdf

R. Xie, S. Nguyen, W. L. Mckeehan, and L. Liu, Acetylated microtubules are required for fusion of autophagosomes with lysosomes, BMC Cell Biol, vol.11, p.89, 2010.
DOI : 10.1186/1471-2121-11-89

URL : https://bmccellbiol.biomedcentral.com/track/pdf/10.1186/1471-2121-11-89

C. M. Xu, W. W. Liu, C. J. Liu, C. Wen, H. F. Lu et al., Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo, Cancer Gene Ther, vol.20, pp.453-460, 2013.

H. Xu, Y. Tian, X. Yuan, Y. Liu, H. Wu et al., Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. OncoTargets Ther, vol.9, pp.431-444, 2016.

Y. Xu, I. Stamenkovic, Y. , and Q. , CD44 attenuates activation of the Hippo signaling pathway and is a prime therapeutic target for glioblastoma, Cancer Res, vol.70, pp.2455-2464, 2010.

M. Yamada, Y. Ichikawa, S. Yamagishi, N. Momiyama, M. Ota et al., Amphiregulin Is a Promising Prognostic Marker for Liver Metastases of Colorectal Cancer, Clin. Cancer Res, vol.14, pp.2351-2356, 2008.

C. Yang, H. K. Graves, I. M. Moya, C. Tao, F. Hamaratoglu et al., , 2015.

, Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules, Proc. Natl. Acad. Sci. U. S. A, vol.112, pp.1785-1790

N. Yang, C. D. Morrison, P. Liu, J. Miecznikowski, W. Bshara et al., TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin, Cell Cycle, vol.11, pp.2922-2930, 2012.

S. Yang, L. Zhang, M. Liu, R. Chong, S. Ding et al., CDK1 Phosphorylation of YAP Promotes Mitotic Defects and Cell Motility and Is Essential for Neoplastic Transformation, Cancer Res, 2013.

S. Yang, L. Zhang, V. Purohit, S. K. Shukla, X. Chen et al.,

, Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3, Oncotarget, vol.6, pp.36019-36031

S. Yang, L. Zhang, X. Chen, Y. Chen, D. et al., Oncoprotein YAP Regulates the Spindle Checkpoint Activation in a Mitotic Phosphorylation-dependent Manner through Up-regulation of BubR1, J. Biol. Chem, vol.290, pp.6191-6202, 2015.

F. Yin, J. Yu, Y. Zheng, Q. Chen, N. Zhang et al., Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2, Cell, vol.154, 2013.

K. Yonesaka, K. Zejnullahu, N. Lindeman, A. J. Homes, D. M. Jackman et al., Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.14, pp.6963-6973, 2008.

B. You, S. Blandin, L. Gérinière, C. Lasset, and P. Souquet, Family mesotheliomas: genetic interaction with environmental carcinogenic exposure?, Bull. Cancer (Paris), vol.94, pp.705-710, 2007.

F. Yu and K. Guan, The Hippo pathway: regulators and regulations, Genes Dev, vol.27, pp.355-371, 2013.
DOI : 10.1101/gad.210773.112

URL : http://genesdev.cshlp.org/content/27/4/355.full.pdf

Q. Yu and I. Stamenkovic, Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion, Genes Dev, vol.13, pp.35-48, 1999.

F. Yu, B. Zhao, N. Panupinthu, J. L. Jewell, I. Lian et al., Regulation of the Hippo-YAP pathway by G-protein coupled receptor signaling, Cell, vol.150, pp.780-791, 2012.

F. Yu, Y. Zhang, H. W. Park, J. L. Jewell, Q. Chen et al., Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation, Genes Dev, vol.27, pp.1223-1232, 2013.

J. Yu, Y. Zheng, J. Dong, S. Klusza, W. Deng et al., Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded, Dev. Cell, vol.18, pp.288-299, 2010.

J. Yu, X. Zhai, X. Li, C. Zhong, C. Guo et al., Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach, 2017.

F. Yuan, Q. Xie, J. Wu, Y. Bai, B. Mao et al., , p.1, 2011.

, Promotes Apoptosis through Regulating Sirt1-dependent p53 Deacetylation, J. Biol. Chem, vol.286, pp.6940-6945

M. Yuan, V. Tomlinson, R. Lara, D. Holliday, C. Chelala et al., Yes-associated protein (YAP) functions as a tumor suppressor in breast, Cell Death Differ, vol.15, p.1752, 2008.

Z. Yuan, M. K. Lehtinen, P. Merlo, J. Villén, S. Gygi et al., Regulation of Neuronal Cell Death by MST1-FOXO1 Signaling, J. Biol. Chem, vol.284, pp.11285-11292, 2009.

D. M. Zaiss, J. Van-loosdregt, A. Gorlani, C. P. Bekker, A. Gröne et al., Amphiregulin enhances regulatory T cell suppressive function via the epidermal growth factor receptor, Immunity, vol.38, pp.275-284, 2013.

D. M. Zaiss, W. C. Gause, L. C. Osborne, and D. Artis, Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair, Immunity, vol.42, pp.216-226, 2015.

G. Zalcman, J. Mazieres, J. Margery, L. Greillier, C. Audigier-valette et al., Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, The Lancet, vol.387, pp.1405-1414, 2016.

F. Zanconato, M. Cordenonsi, and S. Piccolo, YAP/TAZ at the Roots of Cancer, Cancer Cell, vol.29, pp.783-803, 2016.

H. Zhang, C. Liu, Z. Zha, B. Zhao, J. Yao et al., , 2009.

, TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition, J. Biol. Chem, vol.284, pp.13355-13362

J. Zhang, J. Ji, M. Yu, M. Overholtzer, G. A. Smolen et al., YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway, Nat. Cell Biol, vol.11, p.1444, 2009.

L. Zhang, F. Tang, L. Terracciano, D. Hynx, R. Kohler et al., NDR functions as a physiological YAP1 kinase in the intestinal epithelium, Curr. Biol. CB, vol.25, pp.296-305, 2015.

P. Zhang, S. Wang, S. Wang, J. Qiao, L. Zhang et al., Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation, Cell Discov, vol.2, p.16021, 2016.

W. Zhang, J. Zhao, J. Lee, A. Gartung, H. Jawadi et al., , 2013.

, ETS-1-mediated Transcriptional Up-regulation of CD44 Is Required for Sphingosine-1-phosphate Receptor Subtype 3-stimulated Chemotaxis, J. Biol. Chem, vol.288, pp.32126-32137

W. Zhang, Y. Dai, P. Hsu, H. Wang, L. Cheng et al., Targeting YAP in malignant pleural mesothelioma, J. Cell. Mol. Med, vol.21, pp.2663-2676, 2017.

Y. Zhang, K. Mccluskey, K. Fujii, and L. M. Wahl, Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms, J. Immunol. Baltim. Md, vol.161, pp.3071-3076, 1950.

J. Zhao and J. Guan, Signal transduction by focal adhesion kinase in cancer, Cancer Metastasis Rev, vol.28, pp.35-49, 2009.

Y. Zhao, Y. , and X. , Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling, Oncotarget, vol.6, pp.21906-21917, 2015.

B. Zhao, X. Wei, W. Li, R. S. Udan, Q. Yang et al., , 2007.

, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control, Genes Dev, vol.21, pp.2747-2761

B. Zhao, L. Li, and K. Guan, Hippo signaling at a glance, J. Cell Sci, vol.123, pp.4001-4006, 2010.

B. Zhao, K. Tumaneng, and K. Guan, The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal, Nat. Cell Biol, vol.13, p.877, 2011.

B. Zhao, L. Li, L. Wang, C. Wang, J. Yu et al., Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis, Genes Dev, vol.26, pp.54-68, 2012.

Y. Zhao, P. Khanal, P. Savage, Y. She, T. D. Cyr et al., YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway, Cancer Res, vol.74, pp.4493-4503, 2014.

C. Zhu, L. Li, and B. Zhao, The regulation and function of YAP transcription co-activator, Acta Biochim. Biophys. Sin, vol.47, pp.16-28, 2015.

H. Zhu, X. Cheng, X. Niu, Y. Zhang, J. Guan et al., Protonsensing GPCR-YAP Signalling Promotes Cell Proliferation and Survival, Int. J. Biol. Sci, vol.11, pp.1181-1189, 2015.

A. L. Zygulska, K. Krzemieniecki, and P. Pierzchalski, Hippo pathway -brief overview of its relevance in cancer, J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc, vol.68, pp.311-335, 2017.

, Université de Caen Basse-Normandie (Structure d'accueil) les 27 premier mois et au sein de l'unité ISTCT FRE2001 -CNRS-CEA-Normandie Université-Equipe Cervoxy les 8 derniers mois de thèse, Elodie Maille Expériences professionnelles Recherche: Octobre 2014: Doctorat dans l'unité INSERM 1086

, Financement : 50% région Basse-Normandie -50% association des insuffisants respiratoires (AIR), contrat INSERM, pp.2014-2017

. Directeurs-de-thèse, Dr Guénaëlle Levallet (Directeur principal) et Pr Gérard Zalcman

. Nov/juin, Stage de Master 2 recherche (8 mois) dans l'unité INSERM 1086 Cancer et Prévention en collaboration avec le laboratoire OEstrogène Reproduction Cancer (OeReCa), EA2608, 2014.

. Sujet, Etude de la place de la signalisation NF2/RASSF1A/Hippo dans l'agressivité de cellules de lignées mésothéliales pleurales malignes humaines, Encadrants : Pr Gérard Zalcman et Dr Guénaëlle Levallet

. Avril/juin, Master 1 recherche (3 mois), idem Master 2. Sujet : Etude du rôle de RASSF1A dans la mort programmée des cellules de la lignée épithéliale bronchique humaine (HBEC-3) immortalisée. Encadrants : Pr Gérard Zalcman et Dr Guénaëlle Levallet, 2013.

. Avril/juin, Sujet : Effet de co-culture de deux types cellulaires (cellules de Sertoli et germinales) sur l'expression de gènes d'intérêts. Encadrant : Dr Hélène Bouraïma Enseignement: -Biologie animale niveau Licence 1 (39h TP), Stage de DUT (10 semaines) au laboratoire OeReCa, 2011.

, Centre Hospitalier de l'Aigle. Encadrement: -Master 2 (Solenn Brosseau) pendant 10 mois (formation aux techniques et exploitation des résultats) -Plusieurs Licence, Instituts de Formation en Soins Infirmiers et d'aide-Soignant (IFSI), vol.3

, Vulgarisation Scientifique: -Présentation affichée au 19 ème Journée de l'école doctorale NBISE -Intervention dans des collèges/lycées pour la fête de la Science, 2014.

E. Maille, S. Brosseau, V. Hanoux, C. Creveuil, C. Danel et al., By preventing YAP activation, MST1 expression predicts better survival in patients with malignant mesothelioma: Bio-MAPS cohort

M. Keller, F. Dubois, A. Hergovich, E. Maille, J. Camonis et al., Hippo kinases NDR1/2 drive metastasis phenotype of RASSF1A depleted human bronchial epithelial cells (Article en préparation)

E. Maille, S. Brosseau, A. Pham, C. Creveuil, C. Danel et al., La perte d'expression de la kinase MST1 est un facteur de mauvais pronostic chez les patients atteints d'un mésothéliome pleural malin (MPM) : Etude bio-MAPS, Journée normande de recherche biomédicale (JNRb), 2017.

E. Maille, S. Brosseau, A. Pham, C. Creveuil, C. Danel et al., Expression du CD44, de l'amphiréguline et du CD34 chez 448 patients atteints de mésothéliome pleural malin (MPM): Etude bio-MAPS. 9 ème Journées du Cancéropole

F. Dubois, M. Keller, E. Maille, N. Elie, L. Galas et al., Etude de la formation de jonctions communicantes longue distance (nanotubes) entre cellules de lignées épithéliales bronchiques humaines, Embryologistes et Cytologistes, 2016.

C. E. Brosseau, S. Levallet, G. Zalcman, and G. , Des taux élevés de CD44 standard et d'amphiréguline reflètent l'agressivité des cellules de lignées de mésothéliome pleural malin. 19 ème Journée de l'école doctorale NBISE, 2016.

C. E. Brosseau, S. Levallet, G. Zalcman, and G. , Des taux élevés de CD44 standard et d'amphiréguline reflètent l'agressivité des cellules de lignées de mésothéliome pleural malin, ème Journées du Cancéropole, vol.8, 2015.

S. Brosseau, A. Pham, E. Chevalier, C. Creveuil, F. Morin et al., Les hyperméthylations des promoteurs de RASSF2A et MST1 sont-elles des marqueurs pronostiques du mésothéliome pleural malin?, 8 ème Journées du Cancéropole, pp.10-12, 2015.

S. Brosseau, E. Chevalier, A. Pham, C. Creveuil, F. Morin et al., La kinase MST1: un biomarqueur pronostique du mésothéliome pleural malin (MPM)? 11 ème Journées de recherche respiratoire (J2R), vol.2012, 2008.

, Master recherche Physiologie Immunité Différenciation Génétique, option Signalisation, Différenciation Cellulaire, mention Bien

. Dut-génie-biologique, option Analyses Biologiques et Biochimiques

S. Baccalauréat, Science Techniques de Laboratoire), option Biochimie Génie Biologique, mention Assez Bien

M. Keller, A. Hergovich, F. Dubois, E. Chevalier, G. Zalcman et al., Les kinases pro-apoptotiques NDR1/2 sont nécessaires à la motilité des cellules de lignées épithéliales bronchiques humaines dépourvues de RASSF1A, Embryologistes et Cytologistes, 2015.

S. Brosseau, E. Chevalier, A. Pham, C. Creveuil, F. Morin et al., MST1 et RASSF2A, biomarqueurs pronostiques potentiels du mesotheliome pleural malin (MPM)? 20 ème Congrés de pneumologie de langue française (CPLF) -Lille 29-31 janvier, 2016.

C. E. Houllier, L. Levallet, J. Levallet, G. Zalcman, G. H2052 et al., MET-5A : quel(s) modèle(s) choisir pour mieux comprendre l'histoire naturelle du mésothéliome pleurale malin (MPM)? 7 ème Journées du Cancéropole

M. Keller, G. Levallet, F. Dubois, E. Chevalier, G. Zalcman et al., Etude du différentiel des effecteurs terminaux de la voie de signalisation Hippo chez l'homme. 7 ème Journées du Cancéropole, pp.14-16, 2014.

M. Keller, G. Levallet, F. Dubois, E. Chevalier, and G. Zalcman, Yap/Taz: the Janus faces of the Hippo mammals cells signaling integration. 17 ème Journée de l'école doctorale, pp.10-11, 2014.

, Biologie cellulaire : Transfection cellulaire, Test d'invasion, Migration, d'adhésion, d'apoptose, de prolifération, de croissance en agar et culture sphéroide (nucléonsphéra, BD®)

, Biologie moléculaire : Immunofluorescence et Microscopie confocale, Immunohistochimie, ELISA, extraction ARN, ADN et protéique, Western-Blot